<SEC-DOCUMENT>0001193125-24-014919.txt : 20240125
<SEC-HEADER>0001193125-24-014919.hdr.sgml : 20240125
<ACCEPTANCE-DATETIME>20240125085757
ACCESSION NUMBER:		0001193125-24-014919
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240124
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240125
DATE AS OF CHANGE:		20240125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ESGEN Acquisition Corp
		CENTRAL INDEX KEY:			0001865506
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				981601409
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40927
		FILM NUMBER:		24558900

	BUSINESS ADDRESS:	
		STREET 1:		5956 SHERRY LANE, SUITE 1400
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75225
		BUSINESS PHONE:		214-987-6100

	MAIL ADDRESS:	
		STREET 1:		5956 SHERRY LANE, SUITE 1400
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75225
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d662816d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:esac="http://www.esgen-spac.com/20240124" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2024-01-24_to_2024-01-24" name="dei:EntityCentralIndexKey" contextRef="duration_2024-01-24_to_2024-01-24">0001865506</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2024-01-24_to_2024-01-24" name="dei:AmendmentFlag" contextRef="duration_2024-01-24_to_2024-01-24">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="esac-20240124.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2024-01-24_to_2024-01-24"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865506</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-24</xbrli:startDate> <xbrli:endDate>2024-01-24</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CapitalUnitsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865506</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CapitalUnitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-24</xbrli:startDate> <xbrli:endDate>2024-01-24</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865506</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-24</xbrli:startDate> <xbrli:endDate>2024-01-24</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001865506</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-24</xbrli:startDate> <xbrli:endDate>2024-01-24</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p><p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p><p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-01-24_to_2024-01-24" id="Fact_1">8-K</ix:nonNumeric></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-01-24_to_2024-01-24" format="ixt:date-monthname-day-year-en" id="Fact_0">January 24, 2024</ix:nonNumeric></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityRegistrantName">ESGEN ACQUISITION CORPORATION</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen">Cayman Islands</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityFileNumber">001-40927</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityTaxIdentificationNumber">98-1601409</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityAddressAddressLine1">5956 Sherry Lane</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityAddressAddressLine2">Suite 1400</ix:nonNumeric></p><p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityAddressStateOrProvince">TX</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityAddressPostalZipCode">75225</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-01-24_to_2024-01-24" id="Fact_2">214</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-01-24_to_2024-01-24" id="Fact_3">987-6100</ix:nonNumeric></p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"><p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr> </table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CapitalUnitsMember" id="Fact_4">Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CapitalUnitsMember" name="dei:TradingSymbol">ESACU</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CapitalUnitsMember" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember" name="dei:Security12bTitle">Class A ordinary shares included as part of the units</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember" name="dei:TradingSymbol">ESAC</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember" name="dei:Security12bTitle">Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember" name="dei:TradingSymbol">ESACW</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr> </table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="duration_2024-01-24_to_2024-01-24" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p><p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p><p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">First Amendment to the Business Combination Agreement </span></p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, on April&#160;19, 2023, ESGEN Acquisition Corporation, a Cayman Islands exempted company incorporated with limited liability (&#8220;<span style="font-weight:bold"><span style="font-style:italic">ESGEN</span></span>&#8221;), entered into that certain Business Combination Agreement with ESGEN OpCo, LLC, a Delaware limited liability company and wholly-owned subsidiary of ESGEN (&#8220;<span style="font-weight:bold"><span style="font-style:italic">OpCo</span></span>&#8221;), Sunergy Renewables, LLC, a Nevada limited liability company (&#8220;<span style="font-weight:bold"><span style="font-style:italic">Sunergy</span></span>&#8221;), the Sunergy equityholders set forth on the signature pages thereto (collectively, &#8220;<span style="font-weight:bold"><span style="font-style:italic">Sellers</span></span>&#8221; and each, a &#8220;<span style="font-weight:bold"><span style="font-style:italic">Seller</span></span>&#8221;), for limited purposes, ESGEN LLC, a Delaware limited liability company (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Sponsor</span></span>&#8221;), and for limited purposes, Timothy Bridgewater, an individual, in his capacity as the Sellers Representative (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Initial Business Combination Agreement</span></span>&#8221;).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;24, 2024, ESGEN and Sunergy entered into the First Amendment to the Initial Business Combination Agreement (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">First Amendment</span></span>&#8221; and, the Initial Business Combination Agreement as amended by the First Amendment, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Business Combination Agreement</span></span>&#8221;). The First Amendment provides for, among other things, the:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(i)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">reduction of the aggregate consideration to the <span style="white-space:nowrap">pre-transaction</span> Sunergy equityholders from $410&#160;million to $337.3&#160;million;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(ii)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">removal of the (a) $20&#160;million minimum cash condition and (b)&#160;provision requiring forfeiture of founder shares in connection with excess transaction expenses;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(iii)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">modification of the terms and structure of the Sponsor PIPE Investment (as defined below) from $10.0&#160;million in shares of Class&#160;A common stock, par value $0.0001 per share (&#8220;<span style="font-weight:bold"><span style="font-style:italic">New PubCo Class</span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;A Common Stock</span></span>&#8221;), of the continuing entity following the continuation of ESGEN by way of domestication of ESGEN into a Delaware corporation, which continuing entity will be renamed Zeo Energy Corp. (&#8220;<span style="font-weight:bold"><span style="font-style:italic">New PubCo</span></span>&#8221;), to up to $15.0&#160;million in convertible preferred units of OpCo (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Convertible OpCo Preferred Units</span></span>&#8221;) to be issued to the Sponsor pursuant to the Amended and Restated Subscription Agreement (as defined below);</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(iv)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">forfeiture of an aggregate of 2.9&#160;million founder shares and an additional 500,000 founder shares if, within two years of closing of the Business Combination (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Closing</span></span>&#8221;), the Convertible OpCo Preferred Units are redeemed or converted (with such shares subject to a <span style="white-space:nowrap">lock-up</span> for two years after the Closing);</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(v)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">forfeiture of all private warrants to purchase one ESGEN Class&#160;A ordinary share, par value $0.0001 per share, of ESGEN (&#8220;<span style="font-weight:bold"><span style="font-style:italic">ESGEN Private Placement Warrants</span></span>&#8221;);</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(vi)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Sponsor will contribute those certain promissory notes, dated as of April&#160;27, 2021 and October&#160;17, 2023 (which promissory note amended and restated that certain promissory note dated as of April&#160;5, 2023), by and between Sponsor and ESGEN, to ESGEN as a contribution to the capital of ESGEN and all amounts due thereunder will be cancelled; and</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(vii)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">the outside date for the Business Combination to be extended to April&#160;22, 2024.</p></td></tr></table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the First Amendment is filed with this Current Report on Form <span style="white-space:nowrap">8-K</span> (this &#8220;<span style="font-weight:bold"><span style="font-style:italic">Current Report</span></span>&#8221;) as Exhibit 2.1 and is incorporated herein by reference, and the foregoing description of the First Amendment is qualified in its entirety by reference thereto.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">OpCo A&amp;R LLC Agreement </span></p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Following the Business Combination, ESGEN will be organized in an <span style="white-space:nowrap">&#8220;Up-C&#8221;</span> structure, such that Sunergy and the subsidiaries of Sunergy will hold and operate substantially all of the assets and business of ESGEN, and ESGEN will be a publicly listed holding company that will hold a certain amount of common equity interests in OpCo, which will hold all of the equity interests in Sunergy. Until any redemptions or conversions occur as described below, the Sellers will generally hold the remainder of the common equity interests of OpCo through the ownership of their economic, <span style="white-space:nowrap">non-voting</span> Class&#160;B units of OpCo (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Exchangeable OpCo Units</span></span>&#8221;), along with a corresponding amount of <span style="white-space:nowrap">non-economic,</span> voting shares of Class&#160;V common stock, par value $0.0001 per share, of New PubCo (&#8220;<span style="font-weight:bold"><span style="font-style:italic">New PubCo Class</span></span><span style="font-weight:bold"><span style="font-style:italic">&#160;V Common Stock</span></span>&#8221;).</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the Closing, OpCo will amend and restate its limited liability company agreement (as amended, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">OpCo A&amp;R LLC Agreement</span></span>&#8221;) in its entirety to, among other things, provide for:</p><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(i)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">the right of a holder of Exchangeable OpCo Units (subject to certain terms and conditions set forth in the OpCo A&amp;R LLC Agreement) to cause OpCo to redeem one or more of such Exchangeable OpCo Units for shares of New PubCo Class&#160;A Common Stock on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-for-one</span></span> basis (subject to adjustment in certain cases), together with the cancellation of an equal number of shares of New PubCo Class&#160;V Common Stock, as set forth in the OpCo A&amp;R LLC Agreement and the New PubCo&#8217;s certificate of incorporation;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(ii)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">following the first anniversary of the Closing, the right of the Sponsor to (subject to certain terms and conditions set forth in the OpCo A&amp;R LLC Agreement) convert all, but not less than all, of the Sponsor&#8217;s Convertible OpCo Preferred Units into such number of Exchangeable OpCo Units as is determined by dividing (x) $10.00 plus any accrued and unpaid dividends on such Convertible OpCo Preferred Units by (y) $11.00;</p></td></tr></table></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(iii)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">the mandatory conversion of all, but not less than all, of the Sponsor&#8217;s Convertible OpCo Preferred Units outstanding on the Maturity Date (as defined in the OpCo A&amp;R LLC Agreement) into such number of Exchangeable OpCo Units as is determined by dividing (x) $10.00 plus any accrued and unpaid dividends on such Convertible OpCo Preferred Units by (y)&#160;the average of the daily volume weighted average price of New PubCo Class&#160;A Common Stock during the five days prior to the Maturity Date or, if such price is not available, by an independent investment banking firm or other similar party chosen by OpCo;</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(iv)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">the right of the OpCo to redeem the Convertible OpCo Preferred Units at any time prior to the Maturity Date at the return ranging from 110% of the issue price of the Convertible OpCo Preferred Units, less any cash amounts paid on the Convertible OpCo Preferred Units, if such redemption is prior to the first anniversary of the Closing; 125% of the issue price of the Convertible OpCo Preferred Units, less any cash amounts paid on the Convertible OpCo Preferred Units, if such redemption is prior to the first anniversary of the Closing; and 150% of the issue price of the Convertible OpCo Preferred Units, less any cash amounts paid on the Convertible OpCo Preferred Units, if such redemption is prior to the third anniversary of the Closing (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Required Return</span></span>&#8221;); and</p></td></tr></table><p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top">(v)</td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">in the event of certain change of control or financing transactions, the right of the Sponsor to require OpCo to redeem the Sponsor&#8217;s Convertible OpCo Preferred Units at the Required Return or convert such Convertible OpCo Preferred Units into such number of Exchangeable OpCo Units as is determined by dividing (x) $10.00 plus any accrued and unpaid dividends on such Convertible OpCo Preferred Units by (y) $11.00.</p></td></tr></table><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The OpCo A&amp;R LLC Agreement will also provide the holders of Exchangeable OpCo Units with redemption rights in certain limited circumstances, and such Exchangeable OpCo Units will be mandatorily redeemed in connection with certain changes of control. In the event of any conversion of Convertible OpCo Preferred Units as described above, each Exchangeable OpCo Unit received in such conversion (together with an accompanying share of New PubCo Class&#160;V Common Stock) would be immediately exchanged for a share of New PubCo Class&#160;A Common Stock.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The form of the OpCo A&amp;R LLC Agreement is filed with this Current Report as Exhibit D to the First Amendment, which is filed with this Current Report as Exhibit 2.1 and is incorporated herein by reference, and the foregoing description of the OpCo A&amp;R LLC Agreement is qualified in its entirety by reference thereto.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Second Letter Agreement Amendment </span></p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the First Amendment, ESGEN, the Sponsor, the independent directors of the board of directors of ESGEN, and one or more client accounts of Westwood Group Holdings, Inc. (successor to Salient Capital Advisors, LLC) (collectively with the independent directors of the board of directors of ESGEN, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Insiders</span></span>&#8221;) entered into a second amendment (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Second Letter Agreement Amendment</span></span>&#8221;) to that certain Letter Agreement, dated as of October&#160;22, 2021, as amended by that certain Amendment to the Letter Agreement, dated as of April&#160;19, 2023, pursuant to which, among other things, (i)&#160;the Sponsor agreed to irrevocably surrender and forfeit 2,361,641 ESGEN ordinary shares in connection with the Closing, (ii)&#160;the Insiders agreed to irrevocably surrender and forfeit 538,359 ESGEN ordinary shares in connection with Closing, (iii)&#160;the Sponsor and the Insiders agreed to forfeit an additional 500,000 shares of New PubCo Class&#160;A Common Stock if, within two years of Closing, the Convertible OpCo Preferred Units are redeemed or converted (with such shares subject to a <span style="white-space:nowrap">lock-up</span> for two years after Closing) and (iv)&#160;the Sponsor and the Insiders agreed to forfeit all of their ESGEN Private Placement Warrants in connection with Closing.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the Second Letter Agreement Amendment is filed with this Current Report as Exhibit 10.1 and is incorporated herein by reference, and the foregoing description of the Second Letter Agreement Amendment is qualified in its entirety by reference thereto.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amended and Restated Subscription Agreement </span></p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrently with the execution of the First Amendment, ESGEN entered into an amended and restated subscription agreement (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Amended and Restated Subscription Agreement</span></span>&#8221;) with OpCo and the Sponsor. Pursuant to the Amended and Restated Subscription Agreement, the Sponsor agreed to subscribe for and purchase, and OpCo agreed to issue and sell to the Sponsor, concurrently with the Closing, an aggregate of 1.0&#160;million Convertible OpCo Preferred Units (along with an equal number of New PubCo Class&#160;V Common Stock to be issued pursuant to New PubCo&#8217;s certificate of incorporation) for a purchase price of $10.00 per unit, for aggregate gross proceeds of $10.0&#160;million (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Sponsor PIPE Investment</span></span>&#8221;). Additionally, the Amended and Restated Subscription Agreement provides New PubCo and OpCo, at their sole discretion, with the ability to require the Sponsor to purchase, within six (6)&#160;months of the Closing, up to an additional 500,000 Convertible OpCo Preferred Units (along with an equal number of New PubCo Class&#160;V Common Stock to be issued pursuant to New PubCo&#8217;s certificate of incorporation) for a purchase price of $10.00 per unit, for aggregate proceeds collectively up to $15.0&#160;million. The closing of the Sponsor PIPE Investment required to be consummated in connection with the closing of the Business Combination is contingent upon, among other things, the substantially concurrent consummation of the Business Combination. The Amended and Restated Subscription Agreement also provides that ESGEN will grant Sponsor certain customary registration rights.</p></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the Amended and Restated Subscription Agreement is filed with this Current Report as Exhibit 10.2 and is incorporated herein by reference, and the foregoing description of the Amended and Restated Subscription Agreement is qualified in its entirety by reference thereto.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amended and Restated Registration Rights Agreement </span></p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The First Amendment contemplates that, at the Closing, the Sellers, the Sponsor, the Insiders (collectively, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Registration Rights Holders</span></span>&#8221;) and New PubCo will enter into an amended and restated registration rights agreement (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Amended and Restated Registration Rights Agreement</span></span>&#8221;), pursuant to which, among other things, New PubCo, the Sponsor and the Insiders will agree to amend and restate the Registration and Shareholder Rights Agreement, dated as of October&#160;22, 2021, entered into by them in connection with ESGEN&#8217;s initial public offering. Pursuant to the Amended and Restated Registration Rights Agreement, New PubCo will agree that it will use its commercially reasonable efforts to file, within 30 days following the consummation of the Business Combination, a resale shelf registration statement on behalf of the Registration Rights Holders registering (i)&#160;any outstanding shares of New PubCo Class&#160;A Common Stock held by the Registration Rights Holders, (ii)&#160;any shares of New PubCo Class&#160;A Common Stock issued or issuable upon exchange of an equivalent number of Exchangeable OpCo Units and New PubCo Class&#160;V Common Stock issued to the Sellers pursuant to the Business Combination Agreement, (iii)&#160;any shares of New PubCo Class&#160;A Common Stock issued or to be issued to any of the Registration Rights Holders in connection with the Business Combination, (iv)&#160;any shares of New PubCo Class&#160;A Common Stock issued or issuable upon exchange of an equivalent number of Exchangeable OpCo Units (together with the concurrent exchange of an equal number of shares of New PubCo Class&#160;V Common Stock by ESGEN), which are converted from the Convertible OpCo Preferred Units held by the Sponsor, and (v)&#160;any other equity security of New PubCo issued or issuable with respect to any of the foregoing by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Amended and Restated Registration Rights Agreement, in certain circumstances, the Registration Rights Holders can demand ESGEN&#8217;s assistance with underwritten offerings and block trades, subject to certain limitations such as size and value thresholds and customary underwriter cutbacks and issuer blackout periods, and the Registration Rights Holders will also be entitled to certain customary piggyback registration rights.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The form of the Amended and Restated Registration Rights Agreement is filed with this Current Report as Exhibit E to the First Amendment, which is filed with this Current Report as Exhibit 2.1, and the foregoing description of the Amended and Restated Registration Rights Agreement is qualified in its entirety by reference thereto.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;3.02.</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosure set forth above in Item 1.01 of this Current Report is incorporated by reference herein. The Convertible OpCo Preferred Units to be offered and sold in connection with the Sponsor PIPE Investment and the New PubCo Class&#160;V Common Stock issued in connection with the Business Combination have not been and will not be registered under the Securities Act in reliance upon the exemption provided in Section&#160;4(a)(2) thereof.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;7.01</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January 25, 2024, ESGEN and Sunergy issued a joint press release announcing the First Amendment. A copy of the press release is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by reference.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Exchange Act</span></span>&#8221;), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of ESGEN under the Securities Act of 1933, as amended (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Securities Act</span></span>&#8221;) or the Exchange Act, regardless of any general incorporation language in such filings.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward-Looking Statements</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report&#160;contains forward-looking statements within the meaning of Section&#160;27A of the Securities Act and Section&#160;21E of the Exchange Act that are based on beliefs and assumptions and on information currently available to ESGEN and Sunergy. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar references to future periods may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about ESGEN&#8217;s and Sunergy&#8217;s ability to timely effectuate the proposed business combination discussed in this Current Report; the benefits of the proposed business combination; the future financial performance of the combined company following the transactions; changes in ESGEN&#8217;s or Sunergy&#8217;s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, the ability to raise additional funds prior to the Closing and plans and objectives of management. These forward-looking statements are based on information available as of the date of this Current Report,&#160;and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing ESGEN&#8217;s or Sunergy&#8217;s views as of any subsequent date, and none of ESGEN or Sunergy undertakes any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You should not place undue reliance on these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, ESGEN&#8217;s and Sunergy&#8217;s actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: (i)&#160;the timing to complete the proposed business combination; (ii)&#160;the occurrence of any event, change or other circumstances</p></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> that could give rise to the termination of the definitive agreements relating to the proposed business combination; (iii)&#160;the outcome of any legal proceedings that may be instituted against ESGEN, Sunergy or others following announcement of the proposed business combination; (iv)&#160;the inability to complete the proposed business combination due to the failure to obtain the approval of ESGEN shareholders; (v)&#160;the combined company&#8217;s success in retaining or recruiting, or changes required in, its officers, key employees or directors following the proposed business combination; (vi)&#160;the combined company&#8217;s ability to obtain the listing of its common stock and warrants on the Nasdaq following the proposed business combination; (vii)&#160;the risk that the proposed business combination disrupts current plans and operations of Sunergy as a result of the announcement and consummation of the proposed business combination; (viii)&#160;the ability to recognize the anticipated benefits of the proposed business combination; (ix)&#160;unexpected costs related to the proposed business combination; (x)&#160;the amount of any redemptions by public shareholders of ESGEN being greater than expected; (xi)&#160;the management and board composition of the combined company following the proposed business combination; (xii)&#160;limited liquidity and trading of the combined company&#8217;s securities; (xiii)&#160;the use of proceeds not held in ESGEN&#8217;s trust account or available from interest income on the trust account balance; (xiv)&#160;geopolitical risk and changes in applicable laws or regulations; (xv)&#160;the possibility that ESGEN, Sunergy or the combined company may be adversely affected by other economic, business, and/or competitive factors; (xvi)&#160;operational risk; (xvii)&#160;litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on Sunergy&#8217;s resources; (xviii)&#160;the risks that the consummation of the proposed business combination is substantially delayed or does not occur; and (xix)&#160;other risks and uncertainties, including those to be included under the heading &#8220;Risk Factors&#8221; in the registration statement on <span style="white-space:nowrap">Form&#160;S-4</span> filed by ESGEN with the SEC on September&#160;18, <span style="white-space:nowrap">2023&#160;(File&#160;No.&#160;333-274551)&#160;(as&#160;may</span> be amended from time to time, the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Registration Statement</span></span>&#8221;) and those included under the heading &#8220;Risk Factors&#8221; in ESGEN&#8217;s Annual Report on <span style="white-space:nowrap">Form&#160;10-K</span> for the year ended December&#160;31, 2022 (the &#8220;<span style="font-weight:bold"><span style="font-style:italic">Annual Report</span></span>&#8221;) and in its subsequent periodic reports and other filings with the SEC. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by ESGEN, Sunergy, their respective directors, officers or employees or any other person that ESGEN and Sunergy will achieve their objectives and plans in any specified time frame, or at all. The forward-looking statements in this Current Report represent the views of ESGEN and Sunergy as of the date of this Current Report. Subsequent events and developments may cause that view to change. However, while ESGEN and Sunergy may elect to update these forward-looking statements at some point in the future, there is no current intention to do so, except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the views of ESGEN or Sunergy as of any date subsequent to the date of this Current Report.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">No Offer or Solicitation</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report relates to a proposed business combination between ESGEN and Sunergy. This document does not constitute a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Important Information for Investors and Stockholders and Where to Find It</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the proposed business combination between ESGEN and Sunergy, ESGEN filed the Registration Statement initially on September&#160;18, 2023, that includes a preliminary proxy statement/prospectus of ESGEN, and after the Registration Statement is declared effective, ESGEN will mail a definitive proxy statement/prospectus relating to the proposed business combination to ESGEN&#8217;s shareholders. The Registration Statement, including the proxy statement/prospectus contained therein, when declared effective by the SEC, will contain important information about the proposed business combination and the other matters to be voted upon at a meeting of ESGEN&#8217;s shareholders to be held to approve the proposed business combination (and related matters). This Current Report does not contain all the information that should be considered concerning the proposed business combination and other matters and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. ESGEN may also file other documents with the&#160;SEC&#160;regarding the proposed business combination. ESGEN shareholders and other interested persons are advised to read the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement/prospectus, when available, and other documents filed in connection with the proposed business combination, as these materials will contain important information about ESGEN, Sunergy and the proposed business combination.</p></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When available, the definitive proxy statement/prospectus and other relevant materials for the proposed business combination will be mailed to ESGEN shareholders as of a record date to be established for voting on the proposed business combination. Shareholders will also be able to obtain copies of the preliminary proxy statement/prospectus, the definitive proxy statement/prospectus and other documents filed or that will be filed with the SEC, free of charge, by ESGEN through the website maintained by the SEC at&#160;www.sec.gov, or by directing a request to:&#160;ESGEN Acquisition Corporation, 5956&#160;Sherry Lane, Suite 1400, Dallas, TX 75225.</p><p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Participants in the Solicitation</p><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ESGEN and Sunergy and their respective directors, officers and related persons may be deemed participants in the solicitation of proxies of ESGEN shareholders in connection with the proposed business combination. ESGEN shareholders and other interested persons may obtain, without charge, more detailed information regarding the directors and officers of ESGEN, and a description of their interests in ESGEN is contained in ESGEN&#8217;s final prospectus related to its initial public offering, dated&#160;October 21, 2021, the Annual Report and in ESGEN&#8217;s subsequent period reports and other filings with the&#160;SEC. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to ESGEN shareholders in connection with the proposed business combination and other matters to be voted upon at the ESGEN shareholder meeting is set forth in the Registration Statement. Additional information regarding the interests of participants in the solicitation of proxies in connection with the proposed business combination is included in the Registration Statement. You may obtain free copies of these documents as described in the preceding paragraph.</p><p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table><p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">(d) Exhibits </span></p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d662816dex21.htm">Amendment No.&#160;1 to Business Combination Agreement, dated as of January&#160;24, 2024, by and between ESGEN and Sunergy. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d662816dex101.htm">Amendment No.&#160;2 to Letter Agreement, dated as of January&#160;24, 2024, by and among ESGEN, the Sponsor and the Insiders party thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d662816dex102.htm">Amended and Restated Subscription Agreement, dated as of January&#160;24, 2024, by and among ESGEN, OpCo and the Sponsor. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d662816dex991.htm">Press Release, dated as of January&#160;25, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr></table></div></div><p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: January&#160;25, 2024</p><p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">
<tr>
<td style="width:12%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:87%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">ESGEN ACQUISITION CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Andrea Bernatova</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Andrea Bernatova</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Executive Officer</td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d662816dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 1 TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BUSINESS COMBINATION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;1 (this &#147;<B><U>Amendment</U></B>&#148;), dated as of January&nbsp;24, 2024 (the &#147;<B><U>Effective
Date</U></B>&#148;), is made by and between ESGEN Acquisition Corporation, a Cayman Islands exempted company incorporated with limited liability (&#147;<B><U>SPAC</U></B>&#148;), and Sunergy Renewables, LLC, a Nevada limited liability company (the
&#147;<B><U>Company</U></B>&#148;), to that certain Business Combination Agreement, dated as of April&nbsp;19, 2023 (as amended, the &#147;<B><U>BCA</U></B>&#148;), by and among SPAC, the Company and the other parties thereto. Capitalized terms used
but not otherwise defined herein shall have the meanings ascribed to such terms in the BCA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the parties hereto desire to
amend the BCA as set forth herein; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Section&nbsp;9.04 of the BCA provides that, prior to the Closing, the BCA may be
amended by a written instrument executed by the Company and SPAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW</B>,<B> THEREFORE</B>, for good and valuable consideration, the
undersigned each agree as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the fifth recital in the BCA is hereby amended and restated in its entirety as
follows and a new <U>Exhibit J</U> is hereby added to the BCA in the form of <U>Exhibit A</U> attached hereto: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>WHEREAS</B>,
(a)&nbsp;SPAC, certain of its directors, Sponsor and certain other persons party thereto are parties to that certain Letter Agreement, dated October&nbsp;22, 2021, providing that, among other things, such parties will vote their SPAC Class&nbsp;B
Shares in favor of this Agreement and the Transactions, and (b)&nbsp;such parties (i)&nbsp;concurrently with the execution and delivery of this Agreement, amended such letter agreement pursuant to Amendment No.&nbsp;1 to the Letter Agreement, in the
form attached hereto as <U>Exhibit B</U>, and (ii)&nbsp;as of January&nbsp;24, 2024, further amended such letter agreement (as amended, the &#147;<B><U>Sponsor Agreement</U></B>&#148;) pursuant to Amendment No.&nbsp;2 to the Letter Agreement, in the
form attached hereto as <U>Exhibit J</U>;&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the sixth recital in the
BCA is hereby amended and restated in its entirety as follows and <U>Exhibit C</U> of the BCA is hereby replaced by <U>Exhibit B</U> attached hereto: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>WHEREAS</B>, (a)&nbsp;concurrently with the execution and delivery of this Agreement, SPAC entered into a subscription agreement with
Sponsor, which was subsequently amended and restated on January&nbsp;24, 2024 in the form attached hereto as <U>Exhibit C</U> (as amended and restated, the &#147;<B><U>Initial Subscription Agreement</U></B>&#148;), and (b)&nbsp;following the
execution of this Agreement and prior to the Closing, the Company and SPAC will use their reasonable best efforts to identify other investors (collectively with Sponsor, the &#147;<B><U>Investors</U></B>&#148;) to each enter into equity financing
agreements (which may include forward purchase agreements or equity lines of credit), in form and substance reasonably acceptable to SPAC and the Company (each, an &#147;<B><U>Additional Financing Agreement</U></B>&#148; and together with the
Initial Subscription Agreement, the &#147;<B><U>Financing Agreements</U></B>&#148;) (the equity financing under all Financing Agreements, collectively, hereinafter referred to as the &#147;<B><U>Private </U></B><B><U>Placements</U></B>&#148;), on
the terms and subject to the conditions set forth in the applicable Financing Agreement;&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of
the Effective Date, the definition of &#147;Available Financing Proceeds&#148; in the BCA is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B><U>Available Financing Proceeds</U></B>&#148; shall equal, as of the Closing, the unrestricted net cash proceeds to SPAC or
OpCo resulting from the Financing Agreements (which may include forward purchase agreements or equity lines of credit to the extent the same would provide unrestricted cash proceeds to SPAC or OpCo at or prior to the Closing).&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the definition of
&#147;Company Equity Incentive Plan&#148; in the BCA is hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B><U>Company
Equity Incentive Plan</U></B>&#148; means that certain management incentive compensation plan contemplated by the Company to be put in place during the Interim Period (and take effect as of Closing) substantially in accordance with the term sheet
therefor provided to SPAC as of January&nbsp;24, 2024.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the
definition of &#147;OpCo Holder Redemption Right&#148; in the BCA is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B><U>OpCo</U></B><B><U> Holder Redemption Right</U></B>&#148; means, following the Closing, the right of a holder of (i)&nbsp;a
certain class of OpCo Units to cause OpCo to exchange one or more of such OpCo Units for shares of SPAC Class&nbsp;A Common Stock on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis (subject to
adjustment in certain cases), together with the surrender and cancellation of the related shares of SPAC Class&nbsp;V Common Stock, or (ii)&nbsp;OpCo Preferred Units to cause OpCo to (A)&nbsp;convert all of such OpCo Preferred Units for a certain
class of OpCo Units at the conversion ratio set forth in the OpCo A&amp;R LLC Agreement and (B)&nbsp;immediately exchange all such newly issued OpCo Units for shares of SPAC Class&nbsp;A Common Stock on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, together with the surrender and cancellation of the related shares of SPAC Class&nbsp;V Common Stock, in each case of clauses (i)&nbsp;and (ii), as set forth in the OpCo A&amp;R LLC
Agreement and the SPAC Certificate of Incorporation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date,
Section&nbsp;1.01 of the BCA is hereby amended to add the following defined term: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B><U>OpCo Preferred Units</U></B>&#148;
means the Class&nbsp;A Convertible Preferred Units of OpCo, on and after the Closing (after giving effect to the OpCo A&amp;R LLC Agreement).&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the definition of &#147;Seller OpCo Units&#148; in the BCA is hereby amended
and restated in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B><U>Seller OpCo Units</U></B>&#148; means a number of OpCo Units with a value
(valuing each OpCo Unit for such purposes as having a value equal to $10.00) equal to (i) $337,300,000, plus (ii)&nbsp;the amount (if any) of any financing contemplated by the Financing Agreements that is equity financing for equity of the Company
or convertible or exchangeable into or has the right to acquire equity of the Company and is converted to equity of the Company as part of the Company Exchanges, in each case, that is not Company Recapitalization Debt, minus (iii)&nbsp;any Company
Recapitalization Debt.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the definition of &#147;SPAC Class&nbsp;B
Holder Covered Expenses&#148; in the BCA is hereby deleted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the definition
of &#147;Sunergy Transaction Expenses&#148; in the BCA is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;&#147;<B><U>Sunergy Transaction Expenses</U></B>&#148; means (i)&nbsp;all reasonable and documented third-party, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and expenses incurred in connection with, or otherwise related to, the Transactions, the negotiation and preparation of this Agreement and the other
documents contemplated hereby and the performance and compliance with all agreements and conditions contained herein to be performed or complied with at or before the Closing, including the fees, expenses and disbursements of counsel and
accountants, due diligence expenses, advisory and consulting fees and expenses, and other third-party fees (including all expenses related to public readiness and preparing PCAOB financial statements), in each case, of the Company and the Company
Subsidiaries and including any transaction, retention, change in control or similar bonuses, severance payments or other employee-related payments payable by the Company or the Company Subsidiaries as of or after the Closing Date (including the
employer portion of any withholding, payroll, employment or similar Taxes, if any, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
associated therewith) as a result of, or in connection with, the consummation of the Transactions (each, a &#147;<B><U>Change of Control Payment</U></B>&#148;), and (ii)&nbsp;any other fees,
expenses, commissions or other amounts that are allocated to the Company and the Company Subsidiaries pursuant to this Agreement, including (if obtained) the costs of the Company D&amp;O Policy for the initial term thereof. Notwithstanding the
foregoing or anything to the contrary herein, Sunergy Transaction Expenses shall not include any SPAC Transaction Expenses.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;2.01(b) of the BCA is hereby amended and restated in its entirety
as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Recapitalization and Forfeiture</U>. On October&nbsp;23, 2023, prior to effecting any
redemptions in connection with the extension of SPAC&#146;s deadline to consummate its initial Business Combination, SPAC caused each SPAC Class&nbsp;B Share that was held by Sponsor as of such date to be converted into one SPAC Class&nbsp;A Share
(the &#147;<B><U>Sponsor SPAC Share Conversion</U></B>&#148;). At least one day prior to the Closing Date immediately following the transactions effected pursuant to <U>SECTION 2.01(a)</U>, SPAC shall cause each SPAC Class&nbsp;B Share that is
issued and outstanding as of such date to be converted into one SPAC Class&nbsp;A Share (the &#147;<B><U>Other Class</U></B><B><U></U></B><B><U>&nbsp;B Holder SPAC Share Conversion</U></B>&#148; and, together with the Sponsor SPAC Share Conversion,
the &#147;<B><U>SPAC Share Conversion</U></B>&#148;); provided, that (i)&nbsp;prior to the Other Class&nbsp;B Holder SPAC Share Conversion, a number of SPAC Class&nbsp;A Shares that were issued to Sponsor in the Sponsor SPAC Share Conversion equal
to 2,361,641 SPAC Class&nbsp;A Shares shall automatically, and without further action on the part of the Sponsor, be surrendered, forfeited and cancelled, for no consideration and as a contribution to the capital of SPAC, pursuant to and in
accordance with the terms of the Sponsor Agreement, and (ii)&nbsp;the number of SPAC Class&nbsp;A Shares otherwise deliverable to the holders of SPAC Class&nbsp;B Shares pursuant to the Other Class&nbsp;B Holder SPAC Share Conversion shall be
reduced (pro rata between the holders of SPAC Class&nbsp;B Shares) by an amount equal to 538,359 SPAC Class&nbsp;A Shares pursuant to and in accordance with the terms of the Sponsor Agreement. On the Closing Date prior to the Domestication, SPAC,
Sponsor and the other parties to the Sponsor Agreement shall consummate the surrender and forfeiture to, and subsequent cancellation thereof by, SPAC, for no consideration and as a contribution to the capital of SPAC, of all of the SPAC Private
Warrants, pursuant to and in accordance with the terms of the Sponsor Agreement, and no SPAC Private Warrants shall be outstanding or deemed to be outstanding for purposes of <U>SECTION 2.01(c)</U>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;2.01(d) of the BCA is hereby amended and restated in its entirety
as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Private Placements</U>. On the Closing Date, prior to the Closing and immediately
following the transactions effected pursuant to <U>SECTION 2.01(c)</U>, SPAC and OpCo, as applicable, shall cause the Private Placements to be consummated pursuant to and in accordance with the terms of the applicable Financing Agreements.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, a new Section&nbsp;2.04 is hereby added to the BCA as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SECTION 2.04</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Post-Closing Forfeiture</U></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Following the Closing, upon the occurrence of a Triggering Event, (i) 500,000 shares of SPAC Class&nbsp;A Common
Stock (which shall be equitably adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combination, exchange of shares or other like change or transaction with respect to the SPAC
Class&nbsp;A Common Stock occurring after the Closing and prior to the Triggering Event) (the &#147;<B><U>Post-Closing Forfeiture Shares</U></B>&#148;) held by Sponsor and the other parties to the Sponsor Agreement (other than SPAC) originally
issued in connection with the Sponsor SPAC Share Conversion and the Other Class&nbsp;B Holder Share Conversion shall automatically, and without further action on the part of Sponsor or the other parties to the Sponsor Agreement, be surrendered,
forfeited and cancelled (pro rata among Sponsor and the other parties to the Sponsor Agreement (other than SPAC)), for no consideration and as a contribution to the capital of SPAC, pursuant to and in accordance with the terms of the Sponsor
Agreement, (ii)&nbsp;SPAC shall issue a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
number of shares of SPAC Class&nbsp;A Common Stock equal to the number of Post-Closing Forfeiture Shares to the Company, and (iii)&nbsp;the Company shall transfer such shares to Sun Managers,
LLC. If a Triggering Event does not occur within the Forfeiture Period, then Sponsor and the other parties to the Sponsor Agreement (other than SPAC) shall retain the Post-Closing Forfeiture Shares (and such shares shall no longer be subject to
forfeiture hereunder) and Sun Managers, LLC shall have no further right to receive any shares of SPAC Class&nbsp;A Common Stock under this <U>SECTION 2.04</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this <U>SECTION 2.04</U>, a &#147;<B><U>Triggering Event</U></B>&#148; shall mean the date on which
all of the OpCo Preferred Units are redeemed or converted, in each case, in accordance with the OpCo A&amp;R LLC Agreement, within the Forfeiture Period; and the &#147;<B><U>Forfeiture Period</U></B>&#148; shall mean the period beginning on the
Closing Date and ending on the <FONT STYLE="white-space:nowrap">two-year</FONT> anniversary of the Closing Date.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;5.10(a) is hereby amended by adding the following sentence after
the first sentence therein: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;As of January&nbsp;16, 2024, the SPAC Board, by resolutions duly adopted by unanimous vote at a meeting
duly called and held, which resolutions have not been subsequently rescinded or modified in any way, has duly (i)&nbsp;determined that this Agreement (as amended by Amendment No.&nbsp;1 to this Agreement) and the transactions contemplated by this
Agreement (as amended by Amendment No.&nbsp;1 to this Agreement) are in the best interests of SPAC, (ii)&nbsp;approved this Agreement (as amended by Amendment No.&nbsp;1 to this Agreement) and the Transactions and the performance by SPAC of its
obligations under this Agreement (as amended by Amendment No.&nbsp;1 to this Agreement) and the Ancillary Agreements, and (iii)&nbsp;recommended that the shareholders of SPAC approve and adopt this Agreement (as amended by Amendment No.&nbsp;1 to
this Agreement) and the Transactions and directed that this Agreement (as amended by Amendment No.&nbsp;1 to this Agreement) and the Transactions be submitted for consideration by the shareholders of SPAC at the SPAC Shareholders&#146;
Meeting.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the first sentence of Section&nbsp;5.18 of the BCA is
hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;As of January&nbsp;24, 2024, SPAC and OpCo have delivered to the Company a
true, correct and complete copy of the fully executed Initial Subscription Agreement pursuant to which Sponsor has committed, subject to the terms and conditions therein, to purchase an aggregate of up to 1,500,000 OpCo Preferred Units for an
aggregate amount of cash of up to fifteen million dollars ($15,000,000), with an initial purchase of 1,000,000 OpCo Preferred Units for an aggregate amount of cash equal to ten million dollars ($10,000,000) immediately prior to the Closing and an
additional five million dollars ($5,000,000) committed and callable by OpCo at any time within six (6)&nbsp;months of Closing.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;6.02(f) of the BCA is hereby amended and restated in its entirety
as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(f) &nbsp;&nbsp;&nbsp;&nbsp;incur any Indebtedness for borrowed money or issue any debt securities (or warrants or
other rights to acquire any debt securities) or assume, guarantee or otherwise become responsible for, such obligations of any person or persons, except for Indebtedness for borrowed money to be paid off in full at or prior to the Closing in an
amount that does not exceed $2,750,000 in the aggregate (with $750,000 of such amount solely to be used for the payment of expenses related to the satisfaction of Nasdaq listing requirements);&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;7.07(c) of the BCA is hereby amended and restated in its entirety
as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(c)&nbsp;&nbsp;&nbsp;&nbsp;During the Interim Period, SPAC shall use reasonable best efforts to obtain (with the
Company having prior written consent before such policy is obtained and bound) a separate directors&#146; and officers&#146; liability insurance policy (&#147;<B><U>D&amp;O Insurance</U></B>&#148;) that covers (and if obtained shall maintain such
D&amp;O Insurance in effect </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for no less than six (6)&nbsp;years following Closing without any lapse in coverage and continue to honor SPAC&#146;s obligations thereunder) those persons who were managers and officers of the
Company and the Company Subsidiaries prior to the Closing, on the terms of a typical directors&#146; and officers&#146; liability insurance policy for a company whose equity is listed on the Nasdaq and which policy has a scope and amount of coverage
that is reasonably appropriate for a company of similar characteristics (including the line of business and revenues) as the Company (such D&amp;O Insurance, the &#147;<B><U>Company D&amp;O Policy</U></B>&#148;).&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;7.15(a)(ii) of the BCA is hereby amended and restated in its
entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Sponsor SPAC Share Conversion and the Other Class&nbsp;B Holder SPAC Share
Conversion shall each be treated as a &#148;reorganization&#147; within the meaning of Section&nbsp;368(a)(1)(E) of the Code and the Treasury Regulations thereunder;&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;7.15(a)(vii) of the BCA is hereby amended and restated in its
entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(vii)&nbsp;&nbsp;&nbsp;&nbsp;the surrender and forfeiture of SPAC Class&nbsp;A Shares, SPAC Class&nbsp;B
Shares and SPAC Private Warrants by certain holders of SPAC Class&nbsp;A Shares, SPAC Class&nbsp;B Shares and SPAC Private Warrants pursuant to <U>SECTION 2.01(b)</U> shall be treated as a contribution to capital by such holders of SPAC Class&nbsp;A
Shares, SPAC Class&nbsp;B Shares and SPAC Private Warrants to SPAC with respect to which no shares are issued;&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, a new Section&nbsp;7.15(a)(ix) is hereby added to the BCA as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(xi)&nbsp;&nbsp;&nbsp;&nbsp;the surrender and forfeiture of Post-Closing Forfeiture Shares, if any, by the Sponsor and the other parties
to the Sponsor Agreement (other than SPAC) pursuant to <U>SECTION 2.04(a)</U> shall be treated as a contribution to capital by such holders of Post-Closing Forfeiture Shares to SPAC with respect to which no shares are issued.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the second sentence of Section&nbsp;7.15(a) of the BCA is hereby amended and
restated in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;The parties intend that this Agreement constitute and hereby adopt this Agreement as a
&#147;plan of reorganization&#148; with respect to the Domestication, the Sponsor SPAC Share Conversion and the Other Class&nbsp;B Holder SPAC Share Conversion for purposes of Sections 354, 361 and the 368 of the Code and within the meaning of
Treasury Regulations Sections <FONT STYLE="white-space:nowrap">1.368-2(g)</FONT> and <FONT STYLE="white-space:nowrap">1.368-3(a).&#148;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;7.15(c) of the BCA is hereby amended and restated in its entirety
as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(c)&nbsp;&nbsp;&nbsp;&nbsp;SPAC shall (and shall cause its respective affiliates to) provide to the <FONT
STYLE="white-space:nowrap">pre-Closing</FONT> holders of SPAC Common Stock and SPAC Warrants all information reasonably necessary to compute any income of any such holder (or its direct or indirect owners) arising (a)&nbsp;if applicable, as a result
of SPAC&#146;s status as a &#147;passive foreign investment company&#148; within the meaning of Section&nbsp;1297(a) of the Code or a &#147;controlled foreign corporation&#148; within the meaning of Section&nbsp;957(a) of the Code for any taxable
period beginning on or prior to the Closing, including timely providing (i)&nbsp;a PFIC Annual Information Statement to enable such holders to make a &#147;Qualifying Electing Fund&#148; election under Section&nbsp;1295 of the Code for such taxable
period, and (ii)&nbsp;information to enable applicable holders to report their allocable share of &#147;subpart F&#148; income under Section&nbsp;951 of the Code and &#147;global intangible <FONT STYLE="white-space:nowrap">low-taxed</FONT>
income&#148; under Section&nbsp;951A of the Code for such taxable period, and (b)&nbsp;under Section&nbsp;367(b) of the Code and the Treasury Regulations thereunder as a result of the Domestication, the Sponsor SPAC Share Conversion and the Other
Class&nbsp;B Holder SPAC Share Conversion. The parties agree to treat the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
taxable year of SPAC as ending on the date that the Domestication is consummated for U.S. federal income tax purposes.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;7.16(a)(ii) of the BCA is hereby amended and restated in its
entirely as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(ii) &nbsp;&nbsp;&nbsp;&nbsp;five director nominees to be chosen by the Company (at least three of whom shall
also meet the requirements for service on the audit committee of SPAC following Closing under the Exchange Act, Nasdaq rules and SOX).&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, the first sentence of Section&nbsp;7.20 of the BCA is hereby amended and
restated in its entirely as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;SPAC agrees that during the Interim Period, it will continue to extend its deadline to
consummate its initial Business Combination for three (3)&nbsp;monthly periods after January&nbsp;22, 2024 (until April&nbsp;22, 2024) (the &#147;<B><U>Automatic Extension Deadline</U></B>&#148;) in accordance with SPAC&#146;s Organizational
Documents, as amended, and the Trust Agreement (the &#147;<B><U>Automatic Extensions</U></B>&#148; and together with any Charter Amendment Extensions, &#147;<B><U>Extensions</U></B>&#148;), and will pay the amounts required to be deposited into the
Trust Account in accordance with the terms of SPAC&#146;s Organizational Documents.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the
Effective Date, Section&nbsp;8.01(h) of the BCA is hereby amended and restated in its entirety as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>[Reserved]</U>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;9.01(b) of the BCA is hereby amended and restated in its entirety
as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;(b)&nbsp;&nbsp;&nbsp;&nbsp;by either SPAC or the Company if the Closing shall not have occurred prior to April&nbsp;22,
2024 (the &#147;<B><U>Outside Date</U></B>&#148;); provided, however, that this Agreement may not be terminated under this <U>SECTION 9.01(b)</U> by or on behalf of any such party that is in breach or violation of any covenant or agreement contained
in this Agreement and such breach or violation is the principal cause of the failure of a condition set forth in <U>ARTICLE VIII</U> on or prior to the Outside Date; or&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, Section&nbsp;9.03 of the BCA is hereby amended and restated in its entirety as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SECTION 9.03</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Expenses</U></B>. Except as set forth in this <U>SECTION 9.03</U> or
elsewhere in this Agreement, all expenses incurred in connection with this Agreement and the Transactions shall be paid by the party incurring such expenses; provided that if the Closing shall occur, SPAC or OpCo shall, in the following order,
(i)&nbsp;pay or cause to be paid all accrued Sunergy Transaction Expenses and, only up to a maximum of $8,000,000, SPAC Transaction Expenses (including, in each case, any expenses related to the Private Placements and any other financing in
connection with the Transactions) that are unpaid as of immediately prior to the Closing (collectively, the &#147;<B><U>Unpaid Expenses</U></B>&#148;), and (ii)&nbsp;retain all remaining amounts (if any) from the Aggregate Transaction Proceeds on
the balance sheet of OpCo and/or the Company. For all SPAC Transaction Expenses of any kind above $8,000,000, SPAC must pay such expenses in full prior to Closing so that neither SPAC nor OpCo has any liability for such expenses after Closing.
Sponsor and SPAC agree that, prior to or as of the Closing, Sponsor shall contribute those certain promissory notes, dated as of April&nbsp;27, 2021 and October&nbsp;17, 2023 (which promissory note amended and restated that certain promissory note
dated as of April&nbsp;5, 2023), by and between Sponsor and SPAC, to SPAC as a contribution to the capital of SPAC and all amounts due thereunder shall be cancelled and not included as SPAC Transaction Expenses.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp;Effective as of the Effective Date, <U>Exhibit F</U> of the BCA
will be replaced by <U>Exhibit C</U> attached hereto, <U>Exhibit H</U> of the BCA will be replaced by <U>Exhibit D</U> attached hereto and <U>Exhibit A</U> of the BCA will be replaced with <U>Exhibit E</U> attached hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>. This Amendment shall be construed and interpreted in a manner consistent with the provisions
of the BCA. The provisions set forth in Sections 9.05 (Waiver), 10.04 (Severability), 10.06 (Parties in Interest), 10.07 (Governing Law), 10.08 (Waiver of Jury Trial), 10.10 (Counterparts), 10.11 (Specific Performance) and 10.12 (No Recourse) of the
BCA, as in effect as of the date hereof, are hereby incorporated by reference into, and shall be deemed to apply to, this Amendment, <I>mutatis mutandis</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the Effective Date.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B><U>SPAC:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>ESGEN ACQUISITION CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Andrea Bernatova</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrea Bernatova</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDMENT</SMALL>
N<SMALL>O</SMALL>.&nbsp;1 <SMALL>TO</SMALL> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B<SMALL>USINESS</SMALL> C<SMALL>OMBINATION</SMALL> A<SMALL>GREEMENT</SMALL> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B><U>COMPANY:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>SUNERGY RENEWABLES, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tim Bridgewater</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tim Bridgewater</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CEO/CFO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>IGNATURE</SMALL> P<SMALL>AGE</SMALL> <SMALL>TO</SMALL> A<SMALL>MENDMENT</SMALL>
N<SMALL>O</SMALL>.&nbsp;1 <SMALL>TO</SMALL> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B<SMALL>USINESS</SMALL> C<SMALL>OMBINATION</SMALL> A<SMALL>GREEMENT</SMALL> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT J </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form of
Amendment No.&nbsp;2 to the Sponsor Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form of Initial
Subscription Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT F </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form of SPAC
Certificate of Incorporation </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit D </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT H </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form of OpCo
A&amp;R LLC Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit E </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form of Amended
and Restated Registration Rights Agreement </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Omitted] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d662816dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 2 TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LETTER AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Amendment No.&nbsp;2 (this &#147;<B><I>Amendment</I></B>&#148;), dated as of January&nbsp;24, 2024 (the &#147;<B><I>Effective Date</I></B>&#148;) to the Letter Agreement (as defined below) is entered into by and among (i)&nbsp;ESGEN Acquisition
Corporation, a Cayman Islands exempted company (the &#147;<B><I>Company</I></B>&#148;), and (ii)&nbsp;ESGEN LLC, a Delaware limited liability company (&#147;<B><I>Sponsor</I></B>&#148;), and (iii)&nbsp;each of the undersigned, including one or more
client accounts of Salient Capital Partners, LLC, a Texas limited liability company (each, an &#147;<B><I>Insider</I></B>&#148; and, collectively, the &#147;<B><I>Insiders</I></B>&#148;). Capitalized terms used but not defined in this Amendment
shall have the meanings ascribed to them in the Letter Agreement (as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, reference is made to that certain
Business Combination Agreement (as the same may be amended, supplemented or modified, the &#147;<B><I>BCA</I></B>&#148;), dated as of April&nbsp;19, 2023, by and among the Company, ESGEN OpCo, LLC, a Delaware limited liability company and
wholly-owned subsidiary of the Company, the sellers set forth on the signature pages thereto, Sunergy Renewables, LLC, a Nevada limited liability company (&#147;<B><I>Sunergy</I></B>&#148;), solely with respect to Section&nbsp;7.20 and
Section&nbsp;9.03 of the BCA, Sponsor, and Timothy Bridgewater, an individual, in his capacity as the Sellers Representative thereunder, as amended by that certain Amendment No.&nbsp;1 to Business Combination Agreement, dated as of January&nbsp;24,
2024; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company, Sponsor and the Insiders are parties to that certain Letter Agreement, dated as of October&nbsp;22,
2021 (as amended, the &#147;<B><I>Letter Agreement</I></B>&#148;), and that certain Amendment to the Letter Agreement, dated as of April&nbsp;19, 2023; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the parties hereto desire to further amend the Letter Agreement as set forth herein; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Section&nbsp;12 of the Letter Agreement provides that the Letter Agreement may be amended by a written instrument executed by
all parties thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW</B>,<B> THEREFORE</B>, for good and valuable consideration, the undersigned each agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Amendments</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Effective as of the Effective Date, Section&nbsp;5(a) of the Letter Agreement is hereby amended to add the following sentence at the end thereof: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;In addition to the Founder Shares Lock Up, Sponsor and the Insiders agree that they shall not Transfer (other than pursuant to a
forfeiture under Section&nbsp;21(e)), subject to a lien or otherwise encumber any of the Shares Subject to Potential Forfeiture (as defined in Section&nbsp;21) until two (2)&nbsp;years after the completion of the initial Business Combination.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Effective as of the Effective Date, a new Section&nbsp;21 is hereby added to the Letter Agreement as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>21.</B> <B><U>Forfeiture of Founder Shares and Private Placement Warrants</U></B>. The Parties hereto agree that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Prior to the Other Class&nbsp;B Holder SPAC Share Conversion (as defined in the BCA), Sponsor shall
automatically irrevocably surrender and forfeit to the Company for no consideration, as a contribution to capital, 2,361,641 SPAC Class&nbsp;A Shares (as defined in the BCA) (the &#147;<U>Sponsor Forfeited Shares</U>&#148;) that were issued to
Sponsor in the Sponsor SPAC Share Conversion (as defined in the BCA); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In connection with Other Class&nbsp;B Holder SPAC Share Conversion, the number of SPAC Class&nbsp;A Shares
otherwise deliverable to the Insiders pursuant to the Other Class&nbsp;B Holder SPAC Share Conversion shall be reduced (<I>pro rata</I> between the Insiders) by an amount equal to 538,359 SPAC Class&nbsp;A Shares (the &#147;<U>Insider Forfeited
Shares</U>&#148;, and together with the Sponsor Forfeited Shares, the &#147;<U>Forfeited Shares</U>&#148;), and the Insiders shall automatically irrevocably surrender and forfeit to the Company for no consideration, as a contribution to capital,
such Insider Forfeited Shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On the Closing Date prior to the Domestication, Sponsor and the Insiders shall automatically irrevocably
surrender and forfeit to the Company for no consideration, as a contribution to capital, all SPAC Private Warrants (as defined in the BCA) held by Sponsor or the Insiders (collectively, the &#147;<U>Forfeited Warrants</U>&#148;);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Effective upon and subject to the Closing, the Forfeited Shares and the Forfeited Warrants shall be
automatically and immediately cancelled; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Upon the occurrence of the Triggering Event (as defined in the BCA), Sponsor and the Insiders shall
automatically irrevocably surrender and forfeit (<I>pro rata</I> among the Sponsor and each Insider) to the Company for no consideration, as a contribution to capital, 500,000 shares of SPAC Class&nbsp;A Common Stock (as defined in the BCA) (the
&#147;<U>Shares Subject to Potential Forfeiture</U>&#148;) (which shall be equitably adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combination, exchange of shares or other
like change or transaction with respect to the SPAC Class&nbsp;A Common Stock occurring after the closing of the Business Combination and prior to the Triggering Event) that were originally issued to Sponsor in the Sponsor SPAC Share Conversion and
to the Insiders in connection with Other Class&nbsp;B Holder SPAC Share Conversion.&#148; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Effective as of the
Effective Date, Section&nbsp;20 is hereby amended and restated in its entirety as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>20.</B> <B><U>Third Party
Beneficiary</U></B>. The parties acknowledge that Sunergy is entering into the BCA upon reliance of the provisions of this Letter Agreement, together with Amendment No.&nbsp;1 to Letter Agreement, dated as of April&nbsp;19, 2023 (&#147;<B>Amendment
No.</B><B></B><B>&nbsp;1</B>&#148;), and Amendment No.&nbsp;2 to Letter Agreement, dated as of January&nbsp;24, 2024 (&#147;<B>Amendment No.</B><B></B><B>&nbsp;2</B>&#148;), and agree that Sunergy is an express third party beneficiary of the
provisions of Sections 3 and 5 of this Letter Agreement (as amended by Amendment No.&nbsp;1 and Amendment No.&nbsp;2) (and the provisions of Sections 12 through 18 of this Letter Agreement) and Amendment No.&nbsp;1 and Amendment No.&nbsp;2, entitled
to enforce such provisions of this Letter Agreement, Amendment No.&nbsp;1 and Amendment No.&nbsp;2 as if it were a direct party hereto and thereto and shall have the rights of a &#147;party&#148; hereunder and thereunder.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Miscellaneous</U>. Except as expressly provided in this Amendment, all of the terms and provisions in the Letter Agreement are and shall
remain unchanged and in full force and effect, on the terms and subject to the conditions set forth therein. This Amendment does not constitute, directly or by implication, an amendment or waiver of any provision of the Letter Agreement, or any
other right, remedy, power or privilege of any party, except as expressly set forth herein. Any reference to the Letter Agreement in the Letter Agreement or any other agreement, document, instrument or certificate entered into or issued in
connection therewith shall hereinafter mean the Letter Agreement, as amended by this Amendment (or as the Letter Agreement may be further amended or modified after the date hereof in accordance with the terms thereof). The Letter Agreement, as
amended by this Amendment, and the BCA and the documents or instruments attached hereto or thereto or referenced herein or therein, constitutes the entire agreement between the parties with respect to the subject matter of the Letter Agreement, and
supersedes all prior agreements and understandings, both oral and written, between the parties with respect to its subject matter. This Amendment shall be construed, interpreted, governed and enforced in a manner consistent with the provisions of
the BCA. In the event of any conflict between the terms of the Letter, as amended by this Amendment, and the BCA, the terms of the BCA shall govern. This Letter Agreement may not be changed, amended or modified, except by a written instrument
executed by all parties hereto and Sunergy, and no provision hereby may be waived, except in writing signed by the party against whom enforcement of such provision is sought and, with respect to any waiver by the Company, Sunergy. No
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other parties, and any purported assignment
in violation of this provision shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Amendment shall be binding on the Sponsor, each of the Insiders and each of their
respective successors, heirs, personal representatives and assigns and permitted transferees. Other than Sunergy, who is an express third party beneficiary hereunder (and shall have the rights of a &#147;party&#148; under this Amendment, including
without limitation the provisions of the Letter Agreement and the BCA incorporated herein), nothing in this Amendment, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever
under or by reason of this Agreement. The provisions set forth in Sections 10.04 (Severability), 10.07 (Governing Law), 10.08 (Waiver of Jury Trial), 10.9 (Headings), 10.10 (Counterparts), 10.11 (Specific Performance) and 10.12 (No Recourse) and
10.14 (Conflicts and Privilege) of the BCA, as in effect as of the date hereof, are hereby incorporated by reference into, and shall be deemed to apply to, this Amendment, <I>mutatis mutandis</I>. Notwithstanding anything to the contrary contained
herein, in the event that the BCA is terminated in accordance with its terms prior to the Closing, this Amendment shall automatically terminate and become null and void, and the parties shall not have any rights or obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Pages Follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the Effective Date.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ESGEN ACQUISITION CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:<U></U></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Andrea Bernatova</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Andrea Bernatova</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ESGEN LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:<U></U></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ James P. Benson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">James P. Benson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>{Signature Page to Amendment No. 2 to Letter
Agreement</I></B><B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Larry L. Helm</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Larry L. Helm</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mark M. Jacobs</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Mark M. Jacobs</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sanjay Bishnoi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Sanjay Bishnoi</TD></TR>
</TABLE></DIV> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>{Signature Page to Amendment No. 2 to Letter
Agreement</I></B><B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Salient Client Accounts Signature Pages Omitted] </P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>{Signature Page to Amendment No. 2 to Letter
Agreement</I></B><B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acknowledged and agreed </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as of the Effective Date: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SUNERGY RENEWABLES, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Tim Bridgewater</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tim Bridgewater</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CEO/CFO</TD></TR>
</TABLE> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I>{Signature Page to Amendment No. 2 to Letter Agreement</I></B><B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>d662816dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED SUBSCRIPTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ESGEN Acquisition Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5956 Sherry Lane </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Suite 1400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dallas, Texas 75225 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ESGEN OpCo, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5956 Sherry Lane </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Suite 1400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dallas, Texas 75225 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sunergy Renewables, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">255 W 4500 N. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Provo, UT 84604 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Tim Bridgewater </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amended and
Restated Subscription Agreement (this &#147;<U>Subscription Agreement</U>&#148;) is being entered into as of the date set forth on the signature page hereto, by and between ESGEN Acquisition Corporation, a Cayman Islands exempted company, which
shall be domesticated as a Delaware corporation prior to the closing of the Transaction (as defined herein) (together with its successors, including as a result of such domestication, &#147;<U>SPAC</U>&#148;), ESGEN OpCo, LLC, a Delaware limited
liability company and wholly-owned subsidiary of SPAC (&#147;<U>OpCo</U>&#148;), and the undersigned investor (the &#147;<U>Investor</U>&#148;), in connection with the Business Combination Agreement, dated as of April&nbsp;19, 2023 (as amended by
Amendment No.&nbsp;1 on January&nbsp;24, 2024, and as may be amended, supplemented or otherwise modified from time to time, the &#147;<U>Business Combination Agreement</U>&#148;), by and among SPAC, OpCo, Sunergy Renewables, LLC, a Nevada limited
liability company (the &#147;<U>Company</U>&#148;), and the other parties thereto, pursuant to which the parties to the Business Combination Agreement will undertake the transactions described therein (the transactions contemplated by the Business
Combination Agreement, the &#147;<U>Transaction</U>&#148;). In connection with the Transaction, SPAC and OpCo are seeking commitments from interested investors to purchase, following the Domestication (as defined below) and prior to the closing of
the Transaction, Class&nbsp;A Convertible Preferred Units of OpCo (the &#147;<U>Preferred Units</U>&#148;) in a private placement for a purchase price of $10.00 per unit (the &#147;<U>Per Unit Purchase Price</U>&#148;), which Preferred Units will
have the rights and privileges set forth in the amended and restated limited liability company agreement of OpCo substantially in the form attached as <U>Exhibit A</U> hereto (the &#147;<U>OpCo A&amp;R LLC Agreement</U>&#148;), together with an
equal number of shares of Class&nbsp;V Common Stock of SPAC (the &#147;<U>Class</U><U></U><U>&nbsp;V Common Shares</U>&#148;) to be issued in accordance with the SPAC&#146;s certificate of incorporation (as in effect immediately following the
Domestication, the form of which is attached hereto as <U>Exhibit B</U>, the &#147;<U>Charter</U>&#148;) (the Preferred Units and the Class&nbsp;V Common Shares collectively, the &#147;<U>Combined Units</U>&#148;). SPAC and OpCo have or may enter
into subscription agreements (the &#147;<U>Other Subscription Agreements,</U>&#148; and together with this Subscription Agreement, the &#147;<U>Subscription Agreements</U>&#148;) with certain other investors (the &#147;<U>Other Investors,</U>&#148;
and together with the Investor, the &#147;<U>Investors</U>&#148;) pursuant to which the Investors have or will agree to purchase on the closing date of the Transaction, shares of SPAC&#146;s common stock, par value $0.0001 per share (the
&#147;<U>Shares</U>&#148;) or Combined Units. The aggregate purchase price to be paid by the Investor for the subscribed Combined Units at the Initial Closing (as set forth on the signature page hereto) is referred to herein as the &#147;<U>Closing
Subscription Amount</U>&#148; and to the extent so subscribed, the aggregate purchase price to be paid by the Investor for the subscribed Combined Units at the Subsequent Closing (as set forth on the signature page hereto) is referred to herein as
the &#147;<U>Additional Subscription Amount</U>&#148; and the total of the Closing Subscription Amount and the Additional Subscription Amount is referred to herein as the &#147;<U>Subscription Amount</U>.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the closing of the Transaction (and as more fully described in the Business
Combination Agreement), SPAC will domesticate as a Delaware corporation in accordance with Section&nbsp;388 of the General Corporation Law of the State of Delaware and <FONT STYLE="white-space:nowrap">de-register</FONT> as a Cayman Islands exempted
company in accordance with Part XII of the Cayman Islands Companies Act (As Revised) (the &#147;<U>Domestication</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
April&nbsp;9, 2023, SPAC entered into a subscription agreement with Investor, pursuant to which the Investor agreed to subscribe and purchase 1,000,000 shares of SPAC&#146;s Class&nbsp;A common stock, par value $0.0001 per share (the
&#147;<U>Class</U><U></U><U>&nbsp;A Common Stock</U>&#148;), at a price of $10.00 per share (the &#147;<U>Initial Subscription Agreement</U>&#148;). SPAC, OpCo and the Investor desire to amend and restate the Initial Subscription Agreement to update
certain terms contained therein, and hereby agree that this Subscription Agreement amends and restates the Initial Subscription Agreement in its entirety. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection therewith, and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the
conditions, set forth herein, and intending to be legally bound hereby, each of the Investor, OpCo and SPAC acknowledges and agrees as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Subscription</U>. The Investor hereby irrevocably subscribes for and agrees to purchase from OpCo the number of Preferred Units set
forth on the signature page of this Subscription Agreement at a price per Preferred Unit equal to the Per Unit Purchase Price (together with an equal number of Class&nbsp;V Common Shares to be issued by SPAC in accordance with the Charter) on the
terms and subject to the conditions provided for herein. The Investor acknowledges and agrees that OpCo and SPAC reserve the right to accept or reject the Investor&#146;s subscription for the Combined Units for any reason or for no reason, in whole
or in part, at any time prior to its acceptance, and the same shall be deemed to be accepted by OpCo and SPAC only when this Subscription Agreement is signed by a duly authorized person by or on behalf of OpCo and SPAC; OpCo and SPAC may do so in
counterpart form. The Investor acknowledges and agrees that, as a result of the Domestication, the Class&nbsp;V Common Shares that will be received by the Investor and issued by SPAC pursuant to this Subscription Agreement shall be shares of common
stock in a Delaware corporation (and not, for avoidance of doubt, ordinary shares in a Cayman Islands exempted company). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Initial
Closing; Subsequent Closing</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. With respect to the Closing Subscription Amount, the closing of the sale of such Combined Units
contemplated hereby (the &#147;<U>Initial </U><U>Closing</U>&#148;, and the date on which the Initial Closing actually occurs, the &#147;<U>Initial Closing Date</U>&#148;) is contingent upon the consummation of the Domestication and the
substantially concurrent consummation of the Transaction. The Initial Closing shall occur substantially concurrently with and be conditioned upon the effectiveness of, the Transaction. Upon delivery of written notice from (or on behalf of) SPAC and
OpCo to the Investor (the &#147;<U>Initial </U><U>Closing Notice</U>&#148;) that SPAC and OpCo reasonably expect all conditions to the closing of the Transaction to be satisfied or waived on a date that is not less than five (5)&nbsp;business days
from the date on which the Initial Closing Notice is delivered to the Investor, the Investor shall deliver to OpCo, three (3)&nbsp;business days prior to the Initial Closing Date specified in the Initial Closing Notice (the &#147;<U>Scheduled
Initial </U><U>Closing Date</U>&#148;), (i) the Closing Subscription Amount by wire transfer of United States dollars in immediately available funds to the account(s) specified by SPAC and OpCo in the Initial Closing Notice and (ii)&nbsp;any other
information that is reasonably requested in the Initial Closing Notice in order for such Combined Units in respect thereof to be issued to the Investor, including, without limitation, the legal name of the person in whose name such Combined Units
are to be issued and a duly executed Internal Revenue Service Form <FONT STYLE="white-space:nowrap">W-9</FONT> or <FONT STYLE="white-space:nowrap">W-8,</FONT> as applicable. On the Initial Closing Date, a number of Combined Units shall be issued to
the Investor set forth on the signature page to this Subscription Agreement as being issued at the Initial Closing and subsequently such Combined Units shall be registered in book entry form with restrictive legends in the name of the Investor on
OpCo&#146;s unit register or SPAC&#146;s share register, as applicable; provided, however, that the obligation to issue such Combined Units to the Investor is contingent upon OpCo having received the Closing Subscription Amount in full accordance
with this Section&nbsp;2. If the Initial Closing does not occur within ten (10)&nbsp;business days following the Scheduled Initial Closing Date specified in the Initial Closing Notice, SPAC and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
OpCo shall promptly (but not later than three (3)&nbsp;business days thereafter) return the Closing Subscription Amount in full to the Investor; provided, that, unless this Subscription Agreement
has been terminated pursuant to Section&nbsp;9 hereof, such return of funds shall not terminate this Subscription Agreement or relieve the Investor of its obligation to purchase such Combined Units at the Initial Closing upon the delivery by SPAC
and OpCo of a subsequent Initial Closing Notice in accordance with this Section&nbsp;2. For purposes of this Subscription Agreement, &#147;business day&#148; shall mean a day other than a Saturday, Sunday or other day on which commercial banks in
New York, New York are authorized or required by law to close (excluding as a result of &#147;stay at home&#148;, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;shelter-in-place&#148;,</FONT></FONT> <FONT
STYLE="white-space:nowrap">&#147;non-essential</FONT> employee&#148; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer
systems, including for wire transfers, of commercially banking institutions in New York, New York are generally open for use by customers on such day). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. With respect to the Additional Subscription Amount, the closing of the sale of such Combined Units contemplated hereby (the
&#147;<U>Subsequent </U><U>Closing</U>&#148;, and the date on which the Subsequent Closing actually occurs, the &#147;<U>Subsequent Closing Date</U>&#148;) is contingent upon the prior occurrence of the Initial Closing and the issuance of a
Subsequent Closing Notice (as set forth below). Upon delivery of written notice from (or on behalf of) SPAC and OpCo to the Investor (the &#147;<U>Subsequent </U><U>Closing Notice</U>&#148;) of the amount of the Additional Subscription Amount that
SPAC and OpCo desire (at their sole option) to cause Investor to subscribe for, the Investor shall deliver to OpCo, three (3)&nbsp;business days prior to the Subsequent Closing Date specified in the Subsequent Closing Notice (the &#147;<U>Scheduled
Subsequent </U><U>Closing Date</U>&#148;), (i) the portion of the Additional Subscription Amount (which may be any amount up to the total Additional Subscription Amount) by wire transfer of United States dollars in immediately available funds to the
account(s) specified by SPAC and OpCo in the Initial Closing Notice and (ii)&nbsp;any other information that is reasonably requested in the Subsequent Closing Notice in order for such Combined Units in respect thereof to be issued to the Investor,
including, without limitation, the legal name of the person in whose name such Combined Units are to be issued and a duly executed Internal Revenue Service Form <FONT STYLE="white-space:nowrap">W-9</FONT> or
<FONT STYLE="white-space:nowrap">W-8,</FONT> as applicable. On the Subsequent Closing Date, a number of Combined Units shall be issued to the Investor set forth on the signature page to this Subscription Agreement as being issued at the Subsequent
Closing and subsequently such Combined Units shall be registered in book entry form with restrictive legends in the name of the Investor on OpCo&#146;s unit register or SPAC&#146;s share register, as applicable; provided, however, that the
obligation to issue such Combined Units to the Investor is contingent upon OpCo having received the Additional Subscription Amount requested in the Subsequent Closing Notice in full accordance with this Section&nbsp;2. If the Subsequent Closing does
not occur within ten (10)&nbsp;business days following the Scheduled Subsequent Closing Date specified in the Subsequent Closing Notice, SPAC and OpCo shall promptly (but not later than three (3)&nbsp;business days thereafter) return such Additional
Subscription Amount in full to the Investor; provided, that, unless this Subscription Agreement has been terminated pursuant to Section&nbsp;9 hereof, such return of funds shall not terminate this Subscription Agreement or relieve the Investor of
its obligation to purchase such Combined Units at the Subsequent Closing upon the delivery by SPAC and OpCo of a subsequent Subsequent Closing Notice in accordance with this Section&nbsp;2. Any Initial Closing or Subsequent Closing shall be
collectively referred to as a &#147;<U>Closing</U>&#148; and the date on which any Initial Closing or Subsequent Closing occurs shall be collectively referred to as a &#147;<U>Closing Date</U>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Closing Conditions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. The obligation of the parties hereto to consummate the purchase and sale of the Combined Units pursuant to this Subscription Agreement at
the Initial Closing is subject to both of the following conditions (and the obligation of the parties hereto to consummate the purchase and sale of the Combined Units pursuant to this Subscription Agreement at the Subsequent Closing shall be subject
to clause (i)&nbsp;below but not clause (ii)&nbsp;below): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) no applicable governmental authority shall have enacted,
issued, promulgated, enforced or entered any judgment, order, law, rule or regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making the consummation of the transactions contemplated hereby illegal
or otherwise restraining or prohibiting consummation of the transactions contemplated hereby; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) (A) all conditions precedent to the closing of the Transaction
contained in the Business Combination Agreement shall have been satisfied (as determined by the parties to the Business Combination Agreement and other than those conditions under the Business Combination Agreement which, by their nature, are to be
fulfilled at the closing of the Transaction, including to the extent that any such condition is dependent upon the consummation of the purchase and sale of the Combined Units to be purchased at the Initial Closing pursuant to this Subscription
Agreement) or waived according to the terms of the Business Combination Agreement and (B)&nbsp;the closing of the Transaction shall be scheduled to occur concurrently with or on the same date as the Initial Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. The obligation of SPAC and OpCo to consummate the issuance and sale of the Combined Units pursuant to this Subscription Agreement at the
applicable Closing shall be subject to the conditions that (i)&nbsp;all representations and warranties of the Investor contained in this Subscription Agreement applicable to the applicable Closing are true and correct in all material respects at and
as of the applicable Closing (except for representations and warranties qualified by materiality, which shall be true and correct in all respects and those representations and warranties that speak as of a specified earlier date, which shall be so
true and correct in all material respects (or, if qualified by materiality, in all respects) as of such earlier date), and consummation of the applicable Closing shall constitute a reaffirmation by the Investor of each of the representations and
warranties of the Investor contained in this Subscription Agreement as of the applicable Closing; (ii)&nbsp;all obligations, covenants and agreements of the Investor required to be performed by it at or prior to the applicable Closing shall have
been performed in all material respects, and (iii)&nbsp;with respect to the Initial Closing, the Investor shall have delivered to SPAC and OpCo the OpCo A&amp;R LLC Agreement, duly executed by the Investor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. The obligation of the Investor to consummate the purchase of the Combined Units pursuant to this Subscription Agreement at the applicable
Closing shall be subject to the conditions (which may be waived by the Investor) that (i)&nbsp;all representations and warranties of SPAC and OpCo contained in this Subscription Agreement applicable to the applicable Closing shall be true and
correct in all material respects at and as of the applicable Closing (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined herein), which representations and warranties shall be true
in all respects and those representations and warranties that speak as of a specified earlier date, which shall be so true and correct in all material respects (or, if qualified by materiality or Material Adverse Effect, in all respects) as of such
earlier date), and consummation of the applicable Closing shall constitute a reaffirmation by SPAC and OpCo of each of the representations and warranties of SPAC and OpCo contained in this Subscription Agreement as of the applicable Closing;
(ii)&nbsp;all obligations, covenants and agreements of SPAC and OpCo required by this Subscription Agreement to be performed by it at or prior to the applicable Closing shall have been performed in all material respects; (iii)&nbsp;solely with
respect to the Initial Closing, there shall have been no new Other Subscription Agreements, or any amendments, waivers or modifications of Other Subscription Agreements, which have terms and conditions thereunder with respect to the same type of
securities that are materially more advantageous to the Other Investor thereunder as compared to this Subscription Agreement unless Investor has been offered the substantially similar benefits (excluding Strategic Arrangements (as defined below) and
Existing Company Equity Holder Arrangements (as defined below)); and (iv)&nbsp;with respect to the Initial Closing, SPAC and OpCo shall have delivered to the Investor the OpCo A&amp;R LLC Agreement, duly executed by SPAC and OpCo and the other
parties thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Further Assurances</U>. At or prior to the applicable Closing, the parties hereto shall execute and deliver, or
cause to be executed and delivered, such additional documents and take such additional actions as the parties reasonably may deem to be practical and necessary in order to consummate the applicable subscription as contemplated by this Subscription
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>SPAC and OpCo Representations and Warranties</U>. SPAC and OpCo represent and warrant to the Investor that (provided
that no representation or warranty by SPAC shall apply to any statement or information in the SEC Reports (as defined below) that relates to topics referenced in the Statement (as defined below) or any other accounting matters with respect to
SPAC&#146;s securities or expenses or other initial public offering related matters, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nor shall any correction, amendment or restatement of SPAC&#146;s filings or financial statements arising from or relating to the Statement or any other accounting matters, nor any other effects
that relate to or arise out of, or are in connection with or in response to, any of the foregoing or any changes in accounting or disclosure related thereto, be deemed to be material for purposes of this Subscription Agreement or be deemed to be a
breach of any representation or warranty by SPAC or a Material Adverse Effect): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. As of the date hereof, SPAC is an exempted company
duly incorporated, validly existing and in good standing under the laws of the Cayman Islands (to the extent such concept exists in such jurisdiction), and OpCo is a limited liability company duly formed, validly existing and in good standing under
the laws of the State of Delaware. Each of SPAC and OpCo have all power (corporate or otherwise) and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform its
obligations under this Subscription Agreement. As of the applicable Closing, following the Domestication, SPAC will be duly incorporated, validly existing as a corporation and in good standing under the laws of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. As of the applicable Closing, the Combined Units will be duly authorized and, when issued and delivered to the Investor against full
payment therefor in accordance with the terms of this Subscription Agreement, the applicable Combined Units will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and will not have been issued in violation of
any preemptive or similar rights created under the Charter, under the OpCo A&amp;R LLC Agreement (as amended to the applicable Closing Date) or under the laws of the State of Delaware. As of the applicable Closing, the shares of Class&nbsp;A Common
Stock of SPAC to be issued upon the exchange of the Preferred Units (following the conversion of the Preferred Units into common units of OpCo) and the Class&nbsp;V Common Shares (the &#147;<U>Exchanged Shares</U>&#148;) will have been duly
authorized and reserved and, when issued and delivered to the Investor in accordance with the terms of the OpCo A&amp;R LLC Agreement and the Charter, the Exchanged Shares will be validly issued, fully paid and
<FONT STYLE="white-space:nowrap">non-assessable</FONT> and will not have been issued in violation of any preemptive or similar rights created under the Charter or under the laws of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. This Subscription Agreement has been duly authorized, executed and delivered by SPAC and OpCo and, assuming that this Subscription
Agreement constitutes the valid and binding agreement of the Investor, this Subscription Agreement is enforceable against SPAC and OpCo in accordance with its terms, except as may be limited or otherwise affected by (i)&nbsp;bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, or (ii)&nbsp;principles of equity, whether considered at law or equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. The issuance and sale of the applicable Combined Units and the compliance by SPAC and OpCo with all of the provisions of this Subscription
Agreement and the consummation of the transactions contemplated herein will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any
lien, charge or encumbrance upon any of the property or assets of SPAC, OpCo or any of their subsidiaries pursuant to the terms of (i)&nbsp;any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to
which SPAC, OpCo or any of their subsidiaries is a party or by which SPAC, OpCo or any of their subsidiaries is bound or to which any of the property or assets of SPAC or OpCo is subject that would reasonably be expected to materially affect the
validity of the Combined Units or the legal authority of SPAC and OpCo to timely comply in all material respects with the terms of this Subscription Agreement (a &#147;<U>Material Adverse Effect</U>&#148;); (ii) result in any material violation of
the provisions of the organizational documents of SPAC or OpCo after giving effect to the Domestication; or (iii)&nbsp;result in any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency or body,
domestic or foreign, having jurisdiction over SPAC, OpCo or any of their properties that would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. Solely for purposes of the Initial Closing, as of their respective dates for periods prior to the Initial Closing, all reports (the
&#147;<U>SEC Reports</U>&#148;) required to be filed by SPAC with the U.S. Securities and Exchange Commission (the &#147;<U>SEC</U>&#148;) complied in all material respects with the applicable requirements of the Securities Act
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of 1933, as amended (the &#147;<U>Securities Act</U>&#148;), and the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange Act</U>&#148;), and the rules and regulations of the SEC
promulgated thereunder, and none of the SEC Reports, when filed, or, if amended, as of the date of such amendment, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Each Investor acknowledges that (i)&nbsp;the Staff of the SEC (the &#147;<U>Staff</U>&#148;) issued the Staff Statement on Accounting
and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies on April&nbsp;12, 2021 (together with any subsequent guidance, statements or interpretations issued by the SEC or the Staff relating thereto or to other
accounting matters related to SPAC&#146;s securities or expenses or other initial public offering related matters, the &#147;<U>Statement</U>&#148;), (ii)&nbsp;SPAC continues to review the Statement and its implications, including on the financial
statements and other information included in the SEC Reports and (iii)&nbsp;any restatement, revision or other modification of the SEC Reports, including, without limitation, any changes to historical accounting policies of SPAC in connection with
any order, directive, guideline, comment or recommendation from the SEC that is applicable to SPAC, including, without limitation, arising from or relating to SPAC&#146;s review of the Statement shall be deemed not material for purposes of this
Subscription Agreement.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. Solely with respect to the Initial Closing, no Other Subscription Agreement includes terms and conditions with
respect to the same type of securities that are materially more advantageous to any such Other Investor than Investor hereunder, unless Investor has been offered the substantially similar benefits, and such Other Subscription Agreements have not
been amended or modified in any material respect following the date of this Subscription Agreement unless Investor has been offered a substantially similar amendment. For the avoidance of doubt, the foregoing shall exclude (i)&nbsp;any commercial
arrangements (&#147;<U>Strategic Arrangements</U>&#148;) entered into by SPAC, OpCo or the Company with Other Investors constituting Strategic Investors that have executed Other Subscription Agreements and (ii)&nbsp;any arrangements that the Company
has entered, or will enter, into with Other Subscribers that have executed Other Subscription Agreements, which Other Subscribers, as of the date hereof, are equity holders of the Company who have entered or will enter into such arrangements in
their capacity as equity holders of the Company (&#147;<U>Existing Company Equity Holder Arrangements</U>&#148;). For purposes of this provision, &#147;<U>Strategic Investors</U>&#148; shall refer to entities that are (A)&nbsp;not solely or
primarily financial institutions and (B)&nbsp;(i) current or prospective operational, sales or manufacturing customers, suppliers or partners of the Company or its subsidiaries or (ii)&nbsp;entities that operate, sell or manufacture solar or other
renewable energy assets (or entities that supply or serve as operational partners with such entities). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. Assuming the accuracy of the
Investor&#146;s representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;6</U> of this Subscription Agreement, no registration under the Securities Act is required for the offer and sale of the Combined Units by OpCo to the Investor
hereunder. The Combined Units (i)&nbsp;were not offered by any form of general solicitation or general advertising and (ii)&nbsp;are not being offered in a manner involving a public offering under, or in a distribution in violation of, the
Securities Act, or any state securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Investor Representations and Warranties. </U>The Investor represents and warrants to
SPAC that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. The Investor, or each of the funds managed by or affiliated with the Investor for which the Investor is acting as nominee,
as applicable, (i)&nbsp;is a &#147;qualified institutional buyer&#148; (as defined in Rule 144A under the Securities Act) or an institutional &#147;accredited investor&#148; (within the meaning of Rule 501(a)(1), (2), (3), (7), (8), (9), (12) or
(13)&nbsp;of Regulation D under the Securities Act), in each case, satisfying the applicable requirements set forth on <U>Schedule A </U>hereto, (ii)&nbsp;is acquiring the Combined Units only for his, her or its own account and not for the account
of others, or if the Investor is subscribing for the Combined Units as a fiduciary or agent for one or more investor accounts, the Investor has full investment discretion with respect to each such account, and has the full power and authority to
make the acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (iii)&nbsp;is not acquiring the Combined Units with a view to, or for offer or sale in connection with, any distribution thereof in
violation of the Securities Act or any securities laws of the United&nbsp;States or any other jurisdiction. The Investor has completed <U>Schedule A</U> following the signature page hereto and the information contained therein is accurate and
complete. The Investor is not an entity formed for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the specific purpose of acquiring the Combined Units, unless such newly formed entity is an entity in which all of the investors are institutional accredited investors, and is an
&#147;institutional account&#148; as defined by FINRA Rule&nbsp;4512(c). The Investor further acknowledges that it is aware that the sale to it is being made in reliance on a private placement exempt from registration under the Securities Act and is
acquiring the Combined Units for its own account or for an account over which it exercises sole discretion for another qualified institutional buyer or accredited investor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. The Investor (i)&nbsp;is an institutional account as defined in FINRA Rule 4512(c), (ii) is a sophisticated investor, experienced in
investing in private equity transactions and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or securities and (iii)&nbsp;has exercised
independent judgment in evaluating its participation in the purchase of the Combined Units. Accordingly, the Investor understands that the offering meets (i)&nbsp;the exemptions from filing under FINRA Rule 5123(b)(1)(A) and (ii)&nbsp;the
institutional customer exemption under FINRA Rule 2111(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. The Investor acknowledges and agrees that the Combined Units are being
offered in a transaction not involving any public offering within the meaning of the Securities Act and that neither the offer and sale of the Combined Units or Exchanged Shares has been registered under the Securities Act or any other applicable
securities laws. The Investor acknowledges and agrees that neither the Combined Units nor the Exchanged Shares may be offered, resold, transferred, pledged or otherwise disposed of by the Investor absent an effective registration statement under the
Securities Act except in compliance with any exemption therefrom and that any book entries representing the Combined Units or the Exchanged Shares shall contain a restrictive legend to such effect, which legend shall be subject to removal as set
forth herein, subject to applicable law. The Investor acknowledges and agrees that the Combined Units and the Exchanged Shares will be subject to transfer restrictions and, as a result of these transfer restrictions, the Investor may not be able to
readily offer, resell, transfer, pledge or otherwise dispose of the Combined Units or the Exchanged Shares and may be required to bear the financial risk of an investment in the Combined Units or the Exchanged Shares for an indefinite period of
time. The Investor acknowledges and agrees that neither the Combined Units nor the Exchanged Shares will be eligible for offer, resale, transfer, pledge or disposition pursuant to Rule 144 promulgated under the Securities Act until at least one year
from the date that SPAC files a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> following the Closing that includes the &#147;Form 10&#148; information required under applicable SEC rules and regulations. The Investor acknowledges
and agrees that it has been advised to consult legal counsel and tax and accounting advisors prior to making any offer, resale, transfer, pledge or disposition of any of the Combined Units or the Exchanged Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. The Investor acknowledges and agrees that the Investor is purchasing the Preferred Units directly from OpCo and will receive the
Class&nbsp;V Common Shares from SPAC. The Investor further acknowledges that there have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of SPAC, OpCo, the Company, Cohen&nbsp;&amp; Company (the
&#147;<U>Placement Agent</U>&#148;), any of their respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing or any other person or entity, expressly or by implication,
other than those representations, warranties, covenants and agreements of SPAC and OpCo expressly set forth in <U>Section</U><U></U><U>&nbsp;5</U> of this Subscription Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. The Investor&#146;s acquisition and holding of the Combined Units will not constitute or result in a
<FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction under Section&nbsp;406 of the Employee Retirement Income Security Act of 1974, as amended, Section&nbsp;4975 of the Internal Revenue Code of 1986, as amended, or any
applicable similar law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. The Investor acknowledges and agrees that the Investor has received such information as the Investor deems
necessary in order to make an investment decision with respect to the Combined Units, including, with respect to SPAC, OpCo, the Transaction and the business of the Company and its direct and indirect subsidiaries. Without limiting the generality of
the foregoing, the Investor acknowledges that he, she or it has reviewed the SEC Reports and other information as the Investor has deemed necessary to make an investment decision with respect to the Combined Units. The Investor acknowledges and
agrees that the Investor and the Investor&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as the Investor and such Investor&#146;s professional
advisor(s), if any, have deemed necessary to make an investment decision with respect to the Combined Units, including but not limited to access to marketing materials and a virtual data room containing information about SPAC, OpCo and the Company
(and its direct and indirect subsidiaries) and their respective financial condition, results of operations, business, properties, management and prospects sufficient, in the Investor&#146;s judgment, to enable the Investor to evaluate its
investment. The Investor acknowledges that certain information provided by the SPAC or the Company was based on projections, and such projections were prepared based on assumptions and estimates that are inherently uncertain and are subject to a
wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the projections. The Investor further acknowledges that he, she or it has reviewed or
had the full opportunity to review all disclosure documents provided to such Investor in the offering of the Combined Units and no statement or printed material which is contrary to such disclosure documents has been made or given to the Investor by
or on behalf of the SPAC, OpCo or Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. The Investor became aware of this offering of the Combined Units solely by means of direct
contact between the Investor and SPAC, OpCo, the Company or a representative of SPAC, OpCo or the Company, and the Combined Units were offered to the Investor solely by direct contact between the Investor and SPAC, OpCo, the Company or a
representative of SPAC, OpCo or the Company. The Investor did not become aware of this offering of the Combined Units, nor were the Combined Units offered to the Investor, by any other means and none of the SPAC, OpCo, the Company, the Placement
Agent or their respective representatives or any person acting on behalf of any of them acted as investment advisor, broker or dealer to the Investor. The Investor acknowledges that the Combined Units (i)&nbsp;were not offered by any form of general
solicitation or general advertising and (ii)&nbsp;are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. The Investor acknowledges that it is not
relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without limitation, SPAC, OpCo, the Company, the Placement Agent, any of their respective affiliates or any control
persons, officers, directors, employees, partners, agents or representatives of any of the foregoing), other than the representations and warranties of SPAC and OpCo contained in <U>Section</U><U></U><U>&nbsp;5</U> of this Subscription Agreement, in
making its investment or decision to invest in SPAC and OpCo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. The Investor acknowledges that it is aware that there are substantial
risks incident to the purchase and ownership of the Combined Units, including but not limited to those set forth in the SEC Reports. The Investor has such knowledge and experience in financial and business matters as to be capable of evaluating the
merits and risks of an investment in the Combined Units, and the Investor has sought such accounting, legal and tax advice as the Investor has considered necessary to make an informed investment decision and the Investor has made its own assessment
and has satisfied itself concerning relevant tax and other economic considerations relative to its purchase of the Combined Units. The Investor will not look to the Placement Agent for all or part of any such loss or losses the Investor may suffer,
is able to sustain a complete loss on its investment in the Combined Units, has no need for liquidity with respect to its investment in the Combined Units and has no reason to anticipate any change in circumstances, financial or otherwise, which may
cause or require any sale or distribution of all or any part of the Combined Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">i. Alone, or together with any professional
advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment in the Combined Units and determined that the Combined Units are a suitable investment for the Investor and that the Investor is able at this time and
in the foreseeable future to bear the economic risk of a total loss of the Investor&#146;s investment in SPAC and OpCo. The Investor acknowledges specifically that a possibility of total loss exists. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">j. In making its decision to purchase the Combined Units, the Investor has relied solely upon independent investigation made by the Investor.
Without limiting the generality of the foregoing, the Investor has not relied on any statements or other information provided by or on behalf of the Placement Agent or any of its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing concerning SPAC, OpCo, the Company, the Transaction, the
Business Combination Agreement, this Subscription Agreement or the transactions contemplated hereby or thereby, the Combined Units or the offer and sale of the Combined Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">k. The Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Combined
Units or made any findings or determination as to the fairness of this investment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">l. The Investor, if not an individual, has been duly
formed or incorporated and is validly existing and is in good standing under the laws of its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its obligations under this Subscription Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">m. The execution, delivery and performance by the Investor of this Subscription Agreement and the transactions contemplated herein are
within the powers of the Investor, have been duly authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any court or other tribunal or of any governmental commission or agency,
or any agreement or other undertaking, to which the Investor is a party or by which the Investor is bound, and, if the Investor is not an individual, will not violate any provisions of the Investor&#146;s organizational documents, including, without
limitation, its incorporation or formation papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature on this Subscription Agreement is genuine, and the signatory, if the Investor is an individual,
has legal competence and capacity to execute the same or, if the Investor is not an individual, the signatory has been duly authorized to execute the same, and, assuming that this Subscription Agreement constitutes the valid and binding obligation
of SPAC and OpCo, this Subscription Agreement constitutes a legal, valid and binding obligation of the Investor, enforceable against the Investor in accordance with its terms except as may be limited or otherwise affected by (i)&nbsp;bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii)&nbsp;principles of equity, whether considered at law or equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">n. The Investor is not (i)&nbsp;a person or entity named on the List of Specially Designated Nationals and Blocked Persons, the Executive
Order 13599 List, the Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification List, each of which is administered by the U.S. Treasury Department&#146;s Office of Foreign Assets Control (&#147;<U>OFAC</U>&#148;) (collectively,
&#147;<U>OFAC Lists</U>&#148;), (ii) owned, directly or indirectly, or controlled by, or acting on behalf of, one or more persons that are named on the OFAC Lists; (iii)&nbsp;organized, incorporated, established, located, resident or born in, or a
citizen, national or the government, including any political subdivision, agency or instrumentality thereof, of, Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine or any other country or territory embargoed or subject to substantial trade
restrictions by the United States, (iv)&nbsp;a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (v)&nbsp;a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> shell bank or providing banking services
indirectly to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> shell bank (each, a &#147;<U>Prohibited Investor</U>&#148;). The Investor agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable law,
provided that the Investor is permitted to do so under applicable law. Investor represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section&nbsp;5311 et seq.) (the &#147;<U>BSA</U>&#148;), as amended by the
USA PATRIOT Act of 2001 (the &#147;<U>PATRIOT Act</U>&#148;), and its implementing regulations (collectively, the &#147;<U>BSA/PATRIOT Act</U>&#148;), the Investor maintains policies and procedures reasonably designed to comply with applicable
obligations under the BSA/PATRIOT Act. The Investor also represents that, to the extent required, it maintains policies and procedures reasonably designed to ensure compliance with OFAC-administered sanctions programs, including for the screening of
its investors against the OFAC sanctions programs, including the OFAC Lists. The Investor further represents and warrants that, to the extent required by applicable law, the Investor maintains policies and procedures reasonably designed to ensure
that the funds held by the Investor and used to purchase the Combined Units were legally derived and were not obtained, directly or indirectly, from a Prohibited Investor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">o. Neither Investor, nor, to the extent it has them, any of its equity holders, managers, general or limited partners, directors, affiliates
or executive officers (collectively with Investor, the &#147;<U>Covered Persons</U>&#148;), are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subject to any of the &#147;Bad Actor&#148; disqualifications described in Rule 506(d) under the Securities Act (a &#147;<U>Disqualification Event</U>&#148;), except for a Disqualification Event
covered by Rule 506(d)(2) or (d)(3). Investor has exercised reasonable care to determine whether any Covered Person is subject to a Disqualification Event. The acquisition of Combined Units by Investor will not subject SPAC or OpCo to any
Disqualification Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">p. Investor acknowledges its obligations under applicable securities laws with respect to the treatment of <FONT
STYLE="white-space:nowrap">non-public</FONT> information relating to SPAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">q. In connection with the issue and purchase of the Combined
Units, the Placement Agent has not acted as the Investor&#146;s financial advisor or fiduciary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">r. The Investor has or has commitments to
have and, when required to deliver payment to SPAC and OpCo pursuant to <U>Section</U><U></U><U>&nbsp;2</U> above, will have, sufficient funds to pay the Closing Subscription Amount and the Additional Subscription Amount and consummate the
applicable purchase and sale of the Combined Units pursuant to this Subscription Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">s. As of the date hereof, the Investor does
not have, and during the thirty (30)&nbsp;day period immediately prior to the date hereof the Investor has not entered into, any &#147;put equivalent position&#148; as such term is defined in Rule <FONT STYLE="white-space:nowrap">16a-1</FONT> under
the Exchange Act or short sale positions with respect to the securities of the SPAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">t. The Investor is not currently (and at all times
through the applicable Closing will refrain from being or becoming) a member of a &#147;group&#148; (within the meaning of Section&nbsp;13(d)(3) or Section&nbsp;14(d)(2) of the Exchange Act or any successor provision) acting for the purpose of
acquiring, holding, voting or disposing of equity securities of the SPAC or OpCo (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-5(b)(1)</FONT> under the Exchange Act), other than a group consisting solely of the Investor and its
affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">u. Investor understands that the foregoing representations and warranties shall be deemed material to and have been relied
upon by SPAC and OpCo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Conversion Procedures</U>. The OpCo A&amp;R LLC Agreement and the Charter set forth the totality of the
procedures required of the Investor to convert the Combined Units into the Exchanged Shares. SPAC and OpCo shall honor conversions of the Combined Units and SPAC shall deliver the Exchanged Shares in accordance with the terms, conditions and time
periods set forth herein and in the OpCo A&amp;R LLC Agreement and the Charter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Registration Rights</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. In the event that the Exchanged Shares are not registered in connection with the consummation of the Transaction, SPAC agrees that, within
forty-five (45)&nbsp;calendar days after the Initial Closing, it will file with the SEC (at its sole cost and expense) a registration statement registering the resale of the Exchanged Shares (the &#147;<U>Registration Statement</U>&#148;), and it
shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof. SPAC agrees to cause such Registration Statement, or another shelf registration statement that
includes the Exchanged Shares to be sold pursuant to this Subscription Agreement, to remain effective until the earliest of (i)&nbsp;the second anniversary of the Initial Closing, (ii)&nbsp;the date on which the Investor ceases to hold any Combined
Units issued pursuant to this Subscription Agreement, or (iii)&nbsp;on the first date on which the Investor is able to sell all of its Combined Units (or the Exchanged Shares issuable in respect thereof) issued pursuant to this Subscription
Agreement under Rule 144 promulgated under the Securities Act (&#147;<U>Rule 144</U>&#148;) within 90 days without the public information, volume or manner of sale limitations of such rule. The Investor agrees to disclose its ownership to SPAC upon
request to assist it in making the determination with respect to Rule 144 described in clause (iii)&nbsp;above. In no event shall the Investor be identified as a statutory underwriter in the Registration Statement unless in response to a comment or
request from the staff of the SEC or another regulatory agency; <I>provided</I>, that if the SEC requests that the Investor be identified as a statutory underwriter in the Registration Statement, the Investor will have an
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
opportunity to withdraw its Exchanged Shares from the Registration Statement. Notwithstanding the foregoing, if the SEC prevents SPAC from including any or all of the shares proposed to be
registered under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale of the Exchanged Shares by the applicable shareholders or otherwise, such Registration Statement shall register for resale
such number of Exchanged Shares which is equal to the maximum number of Exchanged Shares as is permitted by the SEC. In such event, the number of Exchanged Shares to be registered for each selling shareholder named in the Registration Statement
shall be reduced pro rata among all such selling shareholders. SPAC may amend the Registration Statement so as to convert the Registration Statement to a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> at such time after
SPAC becomes eligible to use such Form <FONT STYLE="white-space:nowrap">S-3.</FONT> The Investor acknowledges and agrees that SPAC may suspend the use of any such registration statement if it determines that in order for such registration statement
not to contain a material misstatement or omission, an amendment thereto would be needed, or if such filing or use could materially affect a bona fide business or financing transaction of SPAC or would require premature disclosure of information
that would adversely affect SPAC that would at that time not otherwise be required in a current, quarterly, or annual report under the Exchange Act, <U>provided</U>, that, (I)&nbsp;SPAC shall not so delay filing or so suspend the use of the
Registration Statement for a period of more than ninety (90)&nbsp;consecutive days or more than a total of one hundred-fifty (150)&nbsp;calendar days in any three hundred sixty (360)&nbsp;day period and (II)&nbsp;SPAC shall use commercially
reasonable efforts to make such Registration Statement available for the sale by the Investor of such securities as soon as practicable thereafter. If so directed by SPAC, the Investor will destroy all copies of the prospectus covering the Exchanged
Shares in the Investor&#146;s possession; provided, however, that this obligation to destroy all copies of the prospectus covering the Exchanged Shares shall not apply (x)&nbsp;to the extent the Investor is required to retain a copy of such
prospectus (A)&nbsp;in order to comply with applicable legal or regulatory requirements or (B)&nbsp;in accordance with a bona fide <FONT STYLE="white-space:nowrap">pre-existing</FONT> document retention policy or (y)&nbsp;to copies stored
electronically on archival servers as a result of automatic data <FONT STYLE="white-space:nowrap">back-up.</FONT> SPAC&#146;s obligations to include the Exchanged Shares issued pursuant to this Subscription Agreement (or shares issued in exchange
therefor) for resale in the Registration Statement are contingent upon the Investor furnishing in writing to SPAC such information regarding the Investor, the securities of SPAC held by the Investor and the intended method of disposition of such
Exchanged Shares, which shall be limited to <FONT STYLE="white-space:nowrap">non-underwritten</FONT> public offerings, as shall be reasonably requested by SPAC to effect the registration of such Exchanged Shares, and shall execute such documents in
connection with such registration as SPAC may reasonably request that are customary of a selling shareholder in similar situations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b.
From and after the Closing, SPAC agrees to indemnify and hold Investor, each person, if any, who controls Investor within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and each affiliate of
Investor within the meaning of Rule 405 under the Securities Act, and each broker, placement agent or sales agent to or through which Investor effects or executes the resale of any Exchanged Shares (collectively, the &#147;<U>Investor Indemnified
Parties</U>&#148;), harmless against any and all losses, claims, damages and liabilities (including any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> legal or other expenses reasonably incurred in
connection with defending or investigating any such action or claim) (collectively, &#147;<U>Losses</U>&#148;) incurred by Investor Indemnified Parties directly that are (i)&nbsp;caused by any untrue statement or alleged untrue statement of a
material fact contained in the Registration Statement or any other registration statement which covers the Exchanged Shares (including, in each case, the prospectus contained therein) or any amendment thereof (including the prospectus contained
therein) or (ii)&nbsp;caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made), not
misleading, except, in the cases of both (i)&nbsp;and (ii), to the extent insofar as the same are caused by or contained in any information or affidavit so furnished in writing to SPAC by Investor for use therein. Notwithstanding the forgoing,
SPAC&#146;s indemnification obligations shall not apply to amounts paid in settlement of any Losses if such settlement is effected without the prior written consent of SPAC (which consent shall not be unreasonably withheld, delayed or conditioned).
Nothing herein shall be read to permit any sale or transfer by Investor of any Exchanged Shares (or Combined Units) at any time during which sale or transfer is not otherwise permitted under the terms of the Charter and/or the OpCo A&amp;R LLC
Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. From and after the Closing, Investor agrees to, severally and not jointly with any Other
Investor or any other selling shareholders using the applicable registration statement, indemnify and hold SPAC, and the officers, employees, directors, partners, members, attorneys and agents of SPAC, each person, if any, who controls SPAC within
the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, and each affiliate of SPAC within the meaning of Rule 405 under the Securities Act (collectively, the &#147;<U>SPAC Indemnified Parties</U>&#148;),
harmless against any and all Losses incurred by the SPAC Indemnified Parties directly that are caused by any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any other registration statement
which covers the Exchanged Shares (including, in each case, the prospectus contained therein) or any amendment thereof (including the prospectus contained therein) or caused by any omission or alleged omission to state therein a material fact
necessary in order to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made), not misleading, to the extent insofar as the same are caused by or contained in any information or
affidavit so furnished in writing to SPAC by Investor expressly for use therein. Notwithstanding the forgoing, Investor&#146;s indemnification obligations shall not apply to amounts paid in settlement of any Losses if such settlement is effected
without the prior written consent of Investor (which consent shall not be unreasonably withheld, delayed or conditioned); provided, however, that the liability of the Investor shall be (x)&nbsp;in proportion to the Investor&#146;s Subscription
Amount compared to the aggregate of all subscription amounts paid pursuant to the Subscription Agreements and (y)&nbsp;limited to the Investor&#146;s Subscription Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Termination</U>. This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and
obligations of the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (a)&nbsp;such date and time as the Business Combination Agreement is terminated in
accordance with its terms without the Transactions being consummated, (b)&nbsp;upon the mutual written agreement of each of the parties hereto, and the Company to terminate this Subscription Agreement, or (c)&nbsp;by written notice by Investor to
SPAC, OpCo and the Company thirty (30)&nbsp;days after the Outside Date (as defined in the Business Combination Agreement), if the Initial Closing has not occurred by such date (provided, that the right to terminate this Subscription Agreement
pursuant to this clause (c)&nbsp;shall not be available to the Investor if the Investor&#146;s breach of any of its covenants or obligations under this Subscription Agreement (or if an affiliate of the Investor is one of the Investors under an Other
Subscription Agreement, and such other Investor&#146;s breach of any of its covenants or obligations under the Other Subscription Agreement), either individually or in the aggregate, shall have proximately caused the failure of the consummation of
the Transaction on or before the Outside Date) (the termination events described in clauses (a)&#150;(c) above, collectively, the &#147;Termination Events&#148;); provided that (i)&nbsp;nothing herein will relieve any party from liability for any
willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from any such willful breach and (ii)&nbsp;the provisions of <U>Sections
9</U>, <U>10</U>, <U>12</U>, <U>13</U> and <U>15</U> of this Subscription Agreement will survive any termination of this Subscription Agreement and continue indefinitely. SPAC and OpCo shall notify the Investor in writing of the termination of the
Business Combination Agreement promptly after the termination of such agreement. Upon the occurrence of any Termination Event, this Subscription Agreement shall be void and of no further effect and any monies paid by the Investor to SPAC and OpCo in
connection herewith shall promptly (and in any event within two&nbsp;(2)&nbsp;business days) following the Termination Event be returned to the Investor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Trust Account Waiver. </U>The Investor acknowledges that SPAC is a blank check company with the powers and privileges to effect a
merger, asset acquisition, reorganization or similar business combination involving SPAC and one or more businesses or assets. The Investor further acknowledges that, as described in the SPAC&#146;s prospectus relating to its initial public offering
dated October&nbsp;19, 2021 (the &#147;<U>Prospectus</U>&#148;) available at www.sec.gov, substantially all of SPAC&#146;s assets consist of the cash proceeds of SPAC&#146;s initial public offering and private placement of its securities, and
substantially all of those proceeds have been deposited in a trust account (the &#147;<U>Trust Account</U>&#148;) for the benefit of SPAC, its public shareholders and the underwriters of SPAC&#146;s initial public offering. Except with respect to
interest earned on the funds held in the Trust Account that may be released to SPAC to pay its tax obligations (and up to $100,000 to pay dissolution expenses), the cash in the Trust Account may be disbursed only for the purposes set forth in the
Prospectus. For and in consideration of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
SPAC entering into this Subscription Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Investor, on behalf of itself and
its affiliates and representatives, notwithstanding anything to the contrary in this Subscription Agreement, hereby irrevocably waives any and all right, title and interest, or any claim of any kind it has or may have in the future, in or to any
monies held in the Trust Account (or distributions therefrom to SPAC&#146;s public shareholders or to the underwriters of SPAC&#146;s initial public offering in respect of their deferred underwriting commissions held in the Trust Account
(&#147;<U>Public Distributions</U>&#148;)), and agrees not to seek recourse against the Trust Account or Public Distributions for any reason whatsoever (regardless of whether such claim arises as a result of, in connection with or relating in any
way to, this Subscription Agreement or any other matter, and regardless of whether such claim arises based on contract, tort, equity or any other theory of legal liability); provided, however, that nothing in this
<U>Section</U><U></U><U>&nbsp;10</U> shall be deemed to limit the Investor&#146;s right, title, interest or claim to any monies held in the Trust Account by virtue of its record or beneficial ownership of Class&nbsp;A Common Stock currently
outstanding on the date hereof, pursuant to a validly exercised redemption right with respect to any such Class&nbsp;A Common Stock, except to the extent that the Investor has otherwise agreed with SPAC to not exercise such redemption right.
Investor agrees and acknowledges that such irrevocable waiver is material to this Subscription Agreement and specifically relied upon by SPAC and its affiliates to induce SPAC to enter in this Subscription Agreement, and Investor further intends and
understands such waiver to be valid, binding and enforceable against Investor and each of its affiliates and representatives under applicable law. Notwithstanding anything to the contrary contained in this Subscription Agreement, the provisions of
this <U>Section</U><U></U><U>&nbsp;10</U> shall survive the Closing or any termination of this Subscription Agreement and last indefinitely. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Tax Treatment</U>. For U.S. federal (and applicable state and local) income tax purposes, (a)&nbsp;the subscription and purchase of
Preferred Units from OpCo shall be treated as a <FONT STYLE="white-space:nowrap">tax-deferred</FONT> contribution of cash to OpCo (as the continuing partnership of the Company pursuant to Section&nbsp;708(a) of the Internal Revenue Code of 1986, as
amended (the &#147;Code&#148;)) in a transaction described under Section&nbsp;721(a) of the Code, and (b)&nbsp;each of the Class&nbsp;V Common Shares received in connection with such subscription and purchase shall be treated as having a fair market
value equal to zero dollars ($0) at the time of Closing. The parties shall not take any action or position that is inconsistent with the foregoing treatment, unless otherwise required by a final determination within the meaning of
Section&nbsp;1313(a) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Miscellaneous</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. Neither this Subscription Agreement nor any rights that may accrue to the parties hereunder (other than the Combined Units acquired
hereunder, if any, and then only to the extent permitted in accordance with the Charter and the OpCo A&amp;R LLC Agreement) may be transferred or assigned without the prior written consent of each of the other parties hereto and the Company;
provided that (i)&nbsp;this Subscription Agreement and any of the Investor&#146;s rights and obligations hereunder may be assigned to any fund or account managed by the same investment manager as the Investor or by an affiliate (as defined in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act) of such investment manager without the prior consent of SPAC, OpCo or the Company and (ii)&nbsp;the Investor&#146;s rights under <U>Section</U><U></U><U>&nbsp;8</U> may be assigned to a
permitted assignee or permitted transferee of the Combined Units (other than in connection with a sale of the Combined Units); provided further that prior to such assignment any such assignee shall agree in writing to be bound by the terms hereof;
provided further, that no assignment pursuant to clause (i)&nbsp;of this <U>Section</U><U></U><U>&nbsp;12(a)</U> shall relieve the Investor of its obligations hereunder unless otherwise agreed to in writing by the SPAC and OpCo. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. SPAC and OpCo may request from the Investor such additional information as SPAC may deem necessary to register the resale of the Exchanged
Shares and evaluate the eligibility of the Investor to acquire the Combined Units, and the Investor shall promptly provide such information as may reasonably be requested to the extent readily available. The Investor acknowledges and agrees that if
it does not provide SPAC with such requested information, SPAC may not be able to register the Investor&#146;s Exchanged Shares for resale pursuant to <U>Section</U><U></U><U>&nbsp;8</U> hereof. The Investor acknowledges that SPAC may file a copy of
this Subscription Agreement (or a form of this Subscription Agreement) with the SEC as an exhibit to a periodic report or a registration statement of SPAC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. The Investor acknowledges that SPAC, OpCo, the Company, the Placement Agent, and others
will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this Subscription Agreement, including <U>Schedule A</U> hereto. Prior to each applicable Closing, the Investor agrees to promptly notify SPAC,
OpCo, the Company and the Placement Agent in writing (including, for the avoidance of doubt, by email) if any of the acknowledgments, understandings, agreements, representations and warranties made by the Investor as set forth in
<U>Section</U><U></U><U>&nbsp;6</U> above are no longer accurate in any material respect (other than those acknowledgments, understandings, agreements, representations and warranties qualified by materiality, in which case the Investor shall notify
SPAC, OpCo, the Company and the Placement Agent if they are no longer accurate in any respect). The Investor acknowledges and agrees that each purchase by the Investor of Preferred Units from OpCo and Class&nbsp;V Common Shares of SPAC, as
applicable, will constitute a reaffirmation of the acknowledgments, understandings, agreements, representations and warranties herein (as modified by any such notice) by the Investor as of the time of such purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. SPAC, OpCo, the Company and the Placement Agent are each entitled to rely upon this Subscription Agreement and each is irrevocably
authorized to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. This Subscription Agreement may not be amended, modified, waived or terminated (other than pursuant to the terms of
<U>Section</U><U></U><U>&nbsp;9</U> above) except by an instrument in writing, signed by each of the parties hereto, <U>provided</U>, <U>however</U>, that no amendment, modification, waiver or termination by SPAC and OpCo of the provisions of this
Subscription Agreement shall be effective without the prior written consent of the Company (other than modifications, amendments or waivers that are solely ministerial in nature or otherwise immaterial and do not affect any economic or any other
material term of this Subscription Agreement). No failure or delay of any party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or any abandonment or
discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties hereunder are cumulative and are not
exclusive of any rights or remedies that they would otherwise have hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. This Subscription Agreement (including the schedule and
exhibits hereto) constitutes the entire agreement, and supersedes all other prior agreements, understandings, representations and warranties, both written and oral, among the parties hereto, with respect to the subject matter hereof. Except as
expressly set forth in this Subscription Agreement with respect to the persons specifically referenced therein, this Subscription Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and their respective
successors and assigns, and the parties hereto acknowledge that such persons so referenced are third party beneficiaries of this Subscription Agreement with right of enforcement for the purposes of, and to the extent of, the rights granted to them,
if any, pursuant to the applicable provisions. Investor acknowledges and agrees that each of the Company and the Placement Agent is a third-party beneficiary of the representations, warranties and covenants of Investor contained in
<U>Section</U><U></U><U>&nbsp;6</U> of this Subscription Agreement, and that the Company is otherwise an express third party beneficiary of this Subscription Agreement, entitled to enforce the terms hereof against Investor as if it were an original
party hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the
parties hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and
be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. If any provision of
this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way
be affected or impaired thereby and shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
continue in full force and effect. Upon such determination that any provision is invalid, illegal or unenforceable, the parties will substitute for any invalid, illegal or unenforceable provision
a suitable and equitable provision that carries out so far as may be valid, legal and enforceable, the intent and purpose of such invalid, illegal or unenforceable provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">i. This Subscription Agreement may be executed and delivered in one (1)&nbsp;or more counterparts (including by electronic means, such as
facsimile, in .pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000) and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so
executed and delivered shall be construed together and shall constitute one and the same agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">j. Each party shall pay all of its
own expenses in connection with this Subscription Agreement and the transactions contemplated herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">k. At any time, the SPAC and OpCo,
with the prior written consent of the Company, may (a)&nbsp;extend the time for the performance of any obligation or other act of the Investor, (b)&nbsp;waive any inaccuracy in the representations and warranties of the Investor contained herein or
in any document delivered by the Investor pursuant hereto and (c)&nbsp;waive compliance with any agreement of the Investor or any condition to its own obligations contained herein. At any time, the Investor may (a)&nbsp;extend the time for the
performance of any obligation or other act of the SPAC or OpCo, (b)&nbsp;waive any inaccuracy in the representations and warranties of the SPAC or OpCo contained herein or in any document delivered by the SPAC or OpCo pursuant hereto and
(c)&nbsp;waive compliance with any agreement of the SPAC or OpCo or any condition to its own obligations contained herein. Any such extension or waiver shall only be valid if set forth in an instrument in writing signed by the party or parties to be
bound thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">l. The parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions of
this Subscription Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto shall be entitled to an injunction or injunctions to prevent breaches of this
Subscription Agreement, without posting a bond or undertaking and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled
at law, in equity, in contract, in tort or otherwise. The parties hereto acknowledge and agree that the Company shall be entitled to specifically enforce the Investor&#146;s obligations to fund the Subscription Amount and the provisions of the
Subscription Agreement of which the Company is an express third party beneficiary, in each case, on the terms and subject to the conditions set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">m. This Subscription Agreement shall be governed by and construed in accordance with the laws of the state of Delaware<B> </B>(regardless of
the laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters (including any action, suit, litigation, arbitration, mediation, claim, charge, complaint, inquiry, proceeding, hearing, audit,
investigation or reviews by or before any governmental entity related hereto), including matters of validity, construction, effect, performance and remedies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">n. Each party hereto hereby, and any person asserting rights as a third party beneficiary may do so only if he, she or it, irrevocably agrees
that any action, suit or proceeding between or among the parties hereto, whether arising in contract, tort or otherwise, arising in connection with any disagreement, dispute, controversy or claim arising out of or relating to this Subscription
Agreement or any related document or any of the transactions contemplated hereby or thereby (&#147;<U>Legal Dispute</U>&#148;) shall be brought only to the exclusive jurisdiction of the courts of the state of New York or the federal courts located
in the Southern District of New York, and each party hereto hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent
permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding that is brought in any such court has been brought in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an inconvenient forum. During the period a Legal Dispute that is filed in accordance with this <U>Section</U><U></U><U>&nbsp;12(n)</U> is pending before a court, all actions, suits or proceedings
with respect to such Legal Dispute or any other Legal Dispute, including any counterclaim, cross-claim or interpleader, shall be subject to the exclusive jurisdiction of such court. Each party hereto and any person asserting rights as a third party
beneficiary may do so only if he, she or it hereby waives, and shall not assert as a defense in any Legal Dispute, that (a)&nbsp;such party is not personally subject to the jurisdiction of the above named courts for any reason, (b)&nbsp;such action,
suit or proceeding may not be brought or is not maintainable in such court, (c)&nbsp;such party&#146;s property is exempt or immune from execution, (d)&nbsp;such action, suit or proceeding is brought in an inconvenient forum, or (e)&nbsp;the venue
of such action, suit or proceeding is improper. A final judgment in any action, suit or proceeding described in this <U>Section</U><U></U><U>&nbsp;12(n)</U> following the expiration of any period permitted for appeal and subject to any stay during
appeal shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable laws. EACH OF THE PARTIES HERETO AND ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY MAY DO SO ONLY
IF HE, SHE OR IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND FOR ANY COUNTERCLAIM
RELATING THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF JURY TRIAL IS PROHIBITED, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL ASSERT IN SUCH LEGAL DISPUTE A NONCOMPULSORY
COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. FURTHERMORE, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL SEEK TO CONSOLIDATE ANY SUCH LEGAL
DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">o. Any notice or communication required
or permitted hereunder to be given to the Investor shall be in writing and either delivered personally, emailed, sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, to such address(es)
or email address(es) set forth on the signature page hereto, and shall be deemed to be given and received (i)&nbsp;when so delivered personally, (ii)&nbsp;when sent, with no mail undeliverable or other rejection notice, if sent by email, or
(iii)&nbsp;three (3) business days after the date of mailing to the address below or to such other address or addresses as such person may hereafter designate by notice given hereunder: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to the Investor, to such address or addresses set forth on the signature page hereto; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to SPAC or OpCo (at or prior to the Initial Closing), to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">ESGEN Acquisition Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">5956 Sherry Lane </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Suite 1400
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Dallas, Texas 75225 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attn:
Andrea Bernatova </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: andrejka.bernatova@esgen-spac.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">with a required copy to (which copy shall not constitute notice): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">4550 Travis Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Dallas,
Texas 75205 </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">Attn:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Kevin Crews, P.C. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Julian Seiguer, P.C.&nbsp;&nbsp;&nbsp;&nbsp; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">Email:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">kevin.crews@kirkland.com </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="8%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">julian.seiguer@kirkland.com </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Sunergy Renewables, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">255 W
4500 N. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Provo, UT 84604 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Tim Bridgewater </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: tim@gosunergy.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Eversheds Sutherland (US) LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">227 W Monroe St., Suite 6000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Chicago, IL 60606 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:
Craig T. Alcorn, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: CraigAlcorn@eversheds-sutherland.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Ellenoff
Grossman&nbsp;&amp; Schole LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">1345 Avenue of the Americas, 11th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York, New York 10105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Matthew A. Gray, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: mgray@egsllp.com </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if to SPAC or OpCo (after the Initial Closing), to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">ESGEN Acquisition Corporation (or the new name to be agreed upon by SPAC and the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Company prior to the Initial Closing) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">255 W 4500 N. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Provo, UT 84604
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Tim Bridgewater </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: tim@gosunergy.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">with
a required copy to (which copy shall not constitute notice): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Eversheds Sutherland (US) LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">227 W Monroe St., Suite 6000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Chicago, IL 60606 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:
Craig T. Alcorn, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: CraigAlcorn@eversheds-sutherland.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Ellenoff
Grossman&nbsp;&amp; Schole LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">1345 Avenue of the Americas, 11th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">New York, New York 10105 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Matthew A. Gray, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: mgray@egsllp.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">p. If
Investor is a Massachusetts Business Trust, a copy of the Declaration of Trust of Investor or any affiliate thereof is on file with the Secretary of State of the Commonwealth of Massachusetts and notice is hereby given that the Subscription
Agreement is executed on behalf of the trustees of Investor or any affiliate thereof as trustees and not individually and that the obligations of the Subscription Agreement are not binding on any of the trustees or stockholders of Investor or any
affiliate thereof individually but are binding only upon Investor or any affiliate thereof and its assets and property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">q. The headings
set forth in this Subscription Agreement are for convenience of reference only and shall not be used in interpreting this Subscription Agreement. In this Subscription Agreement, unless the context </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise requires: (i)&nbsp;any pronoun used shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and
vice versa; (ii)&nbsp;the term &#147;including&#148; (and with correlative meaning &#147;include&#148;) shall be deemed in each case to be followed by the words &#147;without limitation&#148;; and (iii)&nbsp;the words &#147;herein&#148;,
&#147;hereto&#148; and &#147;hereby&#148; and other words of similar import shall be deemed in each case to refer to this Subscription Agreement as a whole and not to any particular portion of this Subscription Agreement. As used in this
Subscription Agreement, the term: (x) &#147;person&#148; shall refer to any individual, corporation, partnership, trust, limited liability company or other entity or association, including any governmental or regulatory body, whether acting in an
individual, fiduciary or any other capacity; and (y) &#147;affiliate&#148; shall mean, with respect to any specified person, any other person or group of persons acting together that, directly or indirectly, through one or more intermediaries
controls, is controlled by or is under common control with such specified person (where the term &#147;control&#148; (and any correlative terms) means the possession, direct or indirect, of the power to direct or cause the direction of the
management and policies of such person, whether through the ownership of voting securities, by contract or otherwise). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U><FONT
STYLE="white-space:nowrap">Non-Reliance</FONT> and Exculpation</U>. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without
limitation, the Placement Agent, any of its respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing), other than the statements, representations and warranties of SPAC
and OpCo expressly contained in <U>Section</U><U></U><U>&nbsp;5</U> of this Subscription Agreement, in making its investment or decision to invest in OpCo and SPAC. The Investor acknowledges and agrees that none of (i)&nbsp;any Other Investor
pursuant to any Other Subscription Agreement (including such Other Investor&#146;s respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing), (ii) the Placement Agent,
its respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing, or (iii)&nbsp;the Company or any other party to the Business Combination Agreement or any Non-Party
Affiliate, shall have any liability to the Investor, or to any Other Investor, pursuant to, arising out of or relating to this Subscription Agreement or any other subscription agreement related to the private placement of the Combined Units, the
negotiation hereof or thereof or its subject matter, or the transactions contemplated hereby or thereby, including, without limitation, with respect to any action heretofore or hereafter taken or omitted to be taken by any of them in connection with
the purchase of the Combined Units or with respect to any claim (whether in tort, contract, under federal or state securities laws or otherwise) for breach of this Subscription Agreement or in respect of any written or oral representations made or
alleged to be made in connection herewith, as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions with respect to any information or materials of any kind furnished by SPAC, OpCo, the Company, the
Placement Agent or any <FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliate concerning SPAC, OpCo, the Company, the Placement Agent, any of their controlled affiliates, this Subscription Agreement or the transactions contemplated hereby. For
purposes of this Subscription Agreement, &#147;<U><FONT STYLE="white-space:nowrap">Non-Party</FONT> Affiliates</U>&#148; means each former, current or future officer, director, employee, partner, member, manager, direct or indirect equityholder or
affiliate of SPAC, OpCo, the Company, the Placement Agent or any of SPAC&#146;s, OpCo&#146;s, the Company&#146;s or the Placement Agent&#146;s controlled affiliates or any family member of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>No Hedging</U>. The Investor agrees that, from the date hereof until the Subsequent Closing (or the latest date the Subsequent Closing
could occur) or the earlier termination of this Subscription Agreement, none of the Investor or any person or entity acting on behalf of the Investor or pursuant to any understanding with the Investor will engage in any hedging or other transactions
or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or similar instrument, including without
limitation equity repurchase agreements and securities lending arrangements, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale, loan, pledge or other disposition or transfer
(whether by the Investor or any other person), in each case, solely to the extent it has the same economic effect as a &#147;short sale&#148; (as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act), of any economic
consequences of ownership (excluding, for the avoidance of doubt, any consequences resulting solely from foreign exchange fluctuations), in whole or in part, directly or indirectly, physically or synthetically, of any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Combined Units or any securities of SPAC, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of securities of SPAC, in cash or
otherwise, or to publicly disclose the intention to undertake any of the foregoing; provided, however, that the provisions of this <U>Section</U><U></U><U>&nbsp;14</U> shall not apply to long sales (including sales of securities held by the
Investor, its controlled affiliates or any person or entity acting on behalf of the Investor or any of its controlled affiliates prior to the date hereof and securities purchased by the Investor in the open market after the date hereof) other than
those effectuated through derivative transactions and similar instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Disclosure</U>. SPAC shall, on or prior to the fourth
(4<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) business day immediately following the date hereof, issue one or more press releases or file with the SEC a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> (collectively,
the &#147;<U>Disclosure Document</U>&#148;) disclosing all material terms of the transactions contemplated hereby and by the Other Subscription Agreements and the amendment to the Business Combination Agreement. Upon the issuance of the Disclosure
Document, to the actual knowledge of SPAC, unless Investor has obtained other material, <FONT STYLE="white-space:nowrap">non-public</FONT> information through a prior relationship with SPAC or the Company or has otherwise obtained material, <FONT
STYLE="white-space:nowrap">non-public</FONT> information other than through the virtual data room established by the Placement Agent in connection with the Transaction specifically for Investors who are to be cleansed upon the issuance of the
Disclosure Document, the Investor shall not be in possession of any material, <FONT STYLE="white-space:nowrap">non-public</FONT> information of SPAC received from SPAC or any of its officers, directors, or employees or agents, and the Investor shall
no longer be subject to any confidentiality or similar obligations under any current agreement, whether written or oral, with SPAC, the Placement Agent or any of its affiliates, relating to the transactions contemplated by this Subscription
Agreement. Investor hereby consents to the publication and disclosure in any press release issued by SPAC or Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed by SPAC with the SEC in connection with the execution and delivery of the Business
Combination Agreement (and any amendment thereof) or this Subscription Agreement and the filing of any related documentation with the SEC (and, as and to the extent otherwise required by the federal securities laws or the SEC or any other securities
authorities, any other documents or communications provided by SPAC to any governmental authority or to security holders of SPAC) of Investor&#146;s identity and beneficial ownership of Combined Units and the nature of Investor&#146;s commitments,
arrangements and understandings under and relating to this Subscription Agreement and, if deemed appropriate by SPAC, a copy of this Subscription Agreement or the form hereof. Investor will promptly provide any information reasonably requested by
SPAC for any regulatory application or filing made or approval sought in connection with the Transaction or the applicable Closing (including filings with the SEC). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>[<I>SIGNATURE PAGES FOLLOW</I>] </U></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the Investor has executed or caused this Subscription Agreement
to be executed by its duly authorized representative as of the date set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name of Investor:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">State/Country of Formation or Domicile:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Jim Benson</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">James P. Benson</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">Authorized Signatory</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name in which Combined Units are to be registered (if different):</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">January&nbsp;24, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Investor&#146;s EIN:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Business Address-Street: 5959 Sherry Lane, Suite 1400</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Mailing Address-Street (if different):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">City, State, Zip: Dallas, TX 75225</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">City, State, Zip:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Attn:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">James Benson</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Attn:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Mike Mayon</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Telephone No.:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Telephone No.:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Facsimile No.:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Facsimile No.:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Number of Combined Units subscribed for: Up to 1,500,000, consisting of 1,000,000 Combined Units at Initial Closing and up to 500,000 Combined Units at any time within six (6)&nbsp;months of Initial Closing (such
subsequent time, if it occurs, the &#147;<U>Subsequent Closing</U>&#148;).</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Aggregate Subscription Amount: $15,000,000</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Price Per Combined Unit: $10.00</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You must pay the Subscription Amount by wire transfer of United States dollars in immediately available funds
to the account specified by SPAC or OpCo in the applicable Closing Notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, SPAC and OpCo have accepted this Subscription Agreement as of the date
set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ESGEN Acquisition Corporation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Andrea Bernatova</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Andrea Bernatova</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ESGEN OpCo, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Andrea Bernatova</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Andrea Bernatova</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: January&nbsp;<U>24</U>, 2024 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acknowledged and agreed </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as of January&nbsp;<U>24</U>, 2024: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sunergy Renewables, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Tim Bridgewater</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tim Bridgewater</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">CEO/CFO</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELIGIBILITY REPRESENTATIONS OF THE INVESTOR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Schedule must be completed by Investor and forms a part of the Subscription Agreement to which it is attached. Capitalized terms used and not otherwise
defined in this Schedule have the meanings given to them in the Subscription Agreement. The Investor must check the applicable box in either Section A or Section B below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">QUALIFIED INSTITUTIONAL BUYER STATUS </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(Please check the applicable subparagraphs): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9746;&nbsp;&nbsp;&nbsp;&nbsp;We are a &#147;qualified institutional buyer&#148; (as defined in Rule 144A under the Securities Act (a
&#147;<U>QIB</U>&#148;)). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">** OR ** </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">INSTITUTIONAL ACCREDITED INVESTOR STATUS </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(Please check the applicable subparagraphs): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;We are an &#147;accredited investor&#148; (within the meaning of Rule 501(a)
under the Securities Act or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the appropriate box <B><I>below</I></B> indicating the
provision under which we qualify as an &#147;accredited investor.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#9744;&nbsp;We are not a natural person. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">** AND ** </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">AFFILIATE STATUS </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Please check the applicable box) INVESTOR: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is not </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">an &#147;affiliate&#148; (as defined in Rule 144 under the Securities Act) of SPAC or acting on behalf of an affiliate of SPAC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rule 501(a) under the Securities Act, in relevant part, states that an &#147;accredited investor&#148; shall mean any person who comes within any of the below
listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated, by marking and initialing the appropriate box below, the
provision(s) below which apply to the Investor and under which the Investor accordingly qualifies as an &#147;accredited investor.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any bank, registered broker or dealer, insurance company, registered investment company, business development
company, or small business investment company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any plan established and maintained by a state, its
political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank,
insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any organization described in Section&nbsp;501(c)(3) of the Internal Revenue Code, corporation, similar business
trust, or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any director, executive officer, or general partner of the
issuer of the securities being offered or sold, or any director, executive officer, or general partner of a general partner of that issuer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any natural person whose individual net worth, or joint net worth with that person&#146;s spouse, exceeds
$1,000,000. For purposes of calculating a natural person&#146;s net worth: (a)&nbsp;the person&#146;s primary residence shall not be included as an asset; (b)&nbsp;indebtedness that is secured by the person&#146;s primary residence, up to the
estimated fair market value of the primary residence at the time of the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of sale of securities exceeds the amount
outstanding sixty (60)&nbsp;days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability); and (c)&nbsp;indebtedness that is secured by the person&#146;s
primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities shall be included as a liability; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or
joint income with that person&#146;s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year (in determining individual &#147;income,&#148; a person should add to
such person&#146;s individual taxable adjusted gross income (exclusive of any spousal or spousal equivalent income) any amounts attributable to tax exempt income received, losses claimed as a limited partner in any limited partnership, deductions
claimed for depletion, contributions to an IRA or Keogh retirement plan, alimony payments, and any amount by which income from long-term capital gains has been reduced in arriving at adjusted gross income); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any natural person holding in good standing one or more professional certifications or designations or
credentials from an accredited educational institution that the SEC has designated as qualifying an individual for accredited investor status, such as a General Securities Representative license (Series 7), a Private Securities Offerings
Representative license (Series 82) and an Investment Adviser Representative license (Series 65); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any trust
with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Any entity in which all of the equity owners are accredited investors meeting one or more of the above tests.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Investor is not an individual, indicate the approximate date Investor entity was formed: <U>April, 2021</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Investor is not an individual, <B><U>initial</U></B> the line below which correctly describes the application of the following statement to Investor&#146;s
situation: Investor (x)&nbsp;was not organized or reorganized for the specific purpose of acquiring the Securities and (y)&nbsp;has made investments prior to the date hereof, and each beneficial owner thereof has and will share in the investment in
proportion to his or her ownership interest in Investor. If the &#147;False&#148; line is initialed, each person participating in the entity will be required to fill out a Subscription Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;JB&nbsp;&nbsp;&nbsp;&nbsp;</U> True </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">__________ False </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>This page
should be completed by the Investor </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>and constitutes a part of the Subscription Agreement. </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of OpCo A&amp;R LLC Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Omitted] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of Charter </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Omitted] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>d662816dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g662816dsp12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g662816dsp12a.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ESGEN Acquisition Corp. Announces Updated Transaction Terms for its Pending Business Combination with
Sunergy Renewables </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DALLAS, TX</B><B></B><B>&nbsp;&amp; NEW PORT RICHEY, FL &#150; January, 25, 2024 &#150; </B><B><U>ESGEN Acquisition
Corp.</U></B><B> (&#147;ESGEN&#148;) (Nasdaq: ESACU, ESAC, ESACW),</B> a special purpose acquisition company, and<B> </B><B><U>Sunergy Renewables, LLC</U></B><B> (&#147;Sunergy&#148; or the &#147;Company&#148;),</B> a leading Florida-based provider
of residential solar and energy efficiency solutions, today announced amended transaction terms for its pending business combination (the &#147;Transaction&#148; or the &#147;Business Combination&#148;) that would result in the combined company
becoming a publicly listed company on the Nasdaq Stock Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By the updated terms of the Transaction, ESGEN&#146;s sponsor, ESGEN LLC (the
&#147;Sponsor&#148;) has committed to purchase up to $15&nbsp;million in Convertible Preferred Equity Securities (the &#147;Convertible Preferred Securities&#148;), of which $10&nbsp;million will be funded at the close of the Business Combination
and the remaining $5&nbsp;million can be funded at the combined company&#146;s discretion up to six months after closing. The purchase of the Convertible Preferred Securities will be funded by Energy Spectrum Partners VIII LP (&#147;Energy
Spectrum&#148;). The updated pro forma implied enterprise value of the combined company is expected to be $390&nbsp;million, and proceeds are expected to be used to fund operations and growth. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We&#146;re confident that these updated terms will allow Sunergy to hit the ground running in the public markets,&#148; said Sunergy CEO Tim
Bridgewater. &#147;With our proprietary, differentiated approach to selling residential solar systems, we&#146;ve demonstrated a strong track record of financial performance and profitability. This amendment to our business combination terms
highlights ESGEN&#146;s continued partnership and commitment to supporting our team as we execute our growth strategy in 2024 and beyond.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We
set out to partner with a stable, innovative, and profitable company, and are confident that our combination with Sunergy will accelerate our path towards being a key player in the residential solar market,&#148; said ESGEN CEO Andrejka Bernatova.
&#147;This amendment is an indication of our commitment to Sunergy as a capable partner that will help us achieve our goals, and we look forward to our future with Tim and the Sunergy team.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This amendment to our business combination terms represents a significant progression in our partnership with Sunergy,&#148; said ESGEN CFO Nader
Daylami. &#147;We believe that these restructured terms position Sunergy to unlock growth both organically and through future M&amp;A moving forward.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amended terms of the Transaction increase the original commitment from Energy Spectrum, in which Energy Spectrum&#146;s participation in the common stock
PIPE was agreed to be $10&nbsp;million at $10.00 per share. In addition, the Sponsor and other insiders agreed to forfeit a total of 2.9&nbsp;million founder shares at the closing, which will leave 4.0&nbsp;million founder shares remaining. The
amended terms of the Transaction also provide that 500,000 additional founder shares will be forfeited if the Convertible Preferred Securities are redeemed or the Sponsor elects to voluntarily convert them, in each case, within 2 years of closing.
Finally, all of the outstanding private placement warrants held by the Sponsor and other insiders will be cancelled at the closing of the Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After the Transaction, the Board of Directors of the combined company will include representatives from both Sunergy and ESGEN. The Board of Directors of
ESGEN and the board of managers of Sunergy have unanimously approved the Transaction. The Completion of the proposed Transaction is subject to customary closing conditions and is anticipated to occur in the first half of 2024. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g662816dsp12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g662816dsp12a.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Founded in 2005 and headquartered in New Port Richey, Florida, Sunergy provides photovoltaic solar and
battery-based power as well as storage systems for residential consumers. With the Company&#146;s carefully assembled product portfolio of solar energy systems, energy-efficient appliances, energy storage, insulation, and roofing services, Sunergy
seeks to provide a range of benefits to homeowners, including meaningful utility cost savings, superior reliability compared to alternative sources, and energy independence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ESGEN is backed by Energy Spectrum, a well-known energy infrastructure investment firm with a track record of more than 25 years, $4.5&nbsp;billion of total
equity capital commitments, and $1.85&nbsp;billion of assets under management as of September&nbsp;30, 2023. The parties believe that the investment track record, operating experience, and strategic insight of Energy Spectrum will serve as a
catalyst to enhance the value of the combined company while generating attractive risk-adjusted returns for its shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information about
the proposed Transaction, including a copy of the original Business Combination agreement and the accompanying investor presentation, please visit the ESGEN investor relations website at <U>esgen-spac.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cohen&nbsp;&amp; Company Capital Markets, a
division of J.V.B. Financial Group, LLC (&#147;CCM&#148;), served as exclusive financial advisor and lead capital markets advisor to ESGEN. Kirkland&nbsp;&amp; Ellis LLP served as legal counsel to ESGEN and Energy Spectrum. Eversheds Sutherland (US)
LLP and Ellenoff Grossman&nbsp;&amp; Schole LLP served as legal counsel to Sunergy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Sunergy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sunergy is a Florida-based regional provider of residential solar, distributed energy, and energy efficiency solutions focused on high growth markets with
limited competitive saturation. With its differentiated sales approach and vertically integrated offerings, Sunergy serves customers who desire to reduce high energy bills and contribute to a more sustainable future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About ESGEN Acquisition Corp. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ESGEN (Nasdaq: ESACU,
ESAC, ESACW) is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. ESGEN
is led by Chief Executive Officer, Andrejka Bernatova and Chief Financial Officer, Nader Daylami, and is affiliated with Energy Spectrum Capital, a Dallas-based private investment firm with long-standing experience building companies across the
energy infrastructure landscape over multiple decades. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Forward-Looking Statements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933, as amended (the &#147;Securities
Act&#148;), and Section&nbsp;21E of the Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to ESGEN and Sunergy. Forward-looking statements include, but are not limited to, statements
that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words &#147;anticipate,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;goal,&#148; &#147;seek,&#148;
&#147;believe,&#148; &#147;project,&#148; </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g662816dsp12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g662816dsp12a.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
&#147;estimate,&#148; &#147;expect,&#148; &#147;strategy,&#148; &#147;future,&#148; &#147;likely,&#148; &#147;may,&#148; &#147;should,&#148; &#147;will&#148; and similar references to future
periods may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about ESGEN&#146;s and Sunergy&#146;s ability to
effectuate the proposed business combination discussed in this news release; the benefits of the proposed business combination; the future financial performance of the combined company following the transactions; changes in ESGEN&#146;s or
Sunergy&#146;s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, the ability to raise additional funds prior to the closing of the business combination and plans and objectives of management.
These forward-looking statements are based on information available as of the date of this news release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking
statements should not be relied upon as representing ESGEN&#146;s or Sunergy&#146;s views as of any subsequent date, and none of ESGEN or Sunergy undertakes any obligation to update forward-looking statements to reflect events or circumstances after
the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You should not place undue reliance on these forward-looking statements. As a result of a number
of known and unknown risks and uncertainties, ESGEN&#146;s and Sunergy&#146;s actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results
to differ include: (i)&nbsp;the timing to complete the proposed business combination; (ii)&nbsp;the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreements relating to the proposed
business combination; (iii)&nbsp;the outcome of any legal proceedings that may be instituted against ESGEN, Sunergy or others following announcement of the proposed business combination; (iv)&nbsp;the inability to complete the proposed business
combination due to the failure to obtain the approval of ESGEN stockholders; (v)&nbsp;the combined company&#146;s success in retaining or recruiting, or changes required in, its officers, key employees or directors following the proposed business
combination; (vi)&nbsp;the combined company&#146;s ability to obtain the listing of its common stock and warrants on the Nasdaq following the proposed business combination; (vii)&nbsp;the risk that the proposed business combination disrupts current
plans and operations of Sunergy as a result of the announcement and consummation of the proposed business combination; (viii)&nbsp;the ability to recognize the anticipated benefits of the proposed business combination; (ix)&nbsp;unexpected costs
related to the proposed business combination; (x)&nbsp;the amount of any redemptions by public stockholders of ESGEN being greater than expected; (xi)&nbsp;the management and board composition of the combined company following the proposed business
combination; (xii)&nbsp;limited liquidity and trading of the combined company&#146;s securities; (xiii)&nbsp;the use of proceeds not held in ESGEN&#146;s trust account or available from interest income on the trust account balance;
(xiv)&nbsp;geopolitical risk and changes in applicable laws or regulations; (xv)&nbsp;the possibility that ESGEN, Sunergy or the combined company may be adversely affected by other economic, business, and/or competitive factors;
(xvi)&nbsp;operational risk; (xvii)&nbsp;litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on Sunergy&#146;s resources; (xviii)&nbsp;the risks that the
consummation of the proposed business combination is substantially delayed or does not occur; and (xix)&nbsp;other risks and uncertainties, including those to be included under the heading &#147;Risk Factors&#148; in the registration statement on
Form <FONT STYLE="white-space:nowrap">S-4</FONT> (as may be amended from time to time, the &#147;Registration Statement&#148;) filed by ESGEN with the SEC and those included under the heading &#147;Risk Factors&#148; in ESGEN&#146;s Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022 (the &#147;Annual Report&#148;) and in its subsequent periodic reports and other filings with the SEC. In light of the significant uncertainties in these
forward-looking statements, you should not regard these statements as a representation or warranty by ESGEN, Sunergy, their respective directors, officers or employees or any other person that ESGEN and Sunergy will achieve their objectives and
plans in any specified time frame, or at all. The forward-looking statements in this news release represent the views </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g662816dsp12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g662816dsp12a.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
of ESGEN and Sunergy as of the date of this news release. Subsequent events and developments may cause that view to change. However, while ESGEN and Sunergy may elect to update these
forward-looking statements at some point in the future, there is no current intention to do so, except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the views of ESGEN
or Sunergy as of any date subsequent to the date of this news release. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>No Offer or Solicitation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This news release relates to a proposed business combination between ESGEN and Sunergy. This document does not constitute a proxy statement or solicitation
of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there
be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of
a prospectus meeting the requirements of the Securities Act. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Important Information for Investors and Stockholders and Where to Find It
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>In connection with the proposed business combination between ESGEN and Sunergy, ESGEN filed the Registration Statement that includes a
preliminary proxy statement/prospectus of ESGEN, and after the Registration Statement is declared effective, ESGEN will mail a definitive proxy statement/prospectus relating to the proposed business combination to ESGEN&#146;s stockholders. The
Registration Statement, including the proxy statement/prospectus contained therein, when declared effective by the&nbsp;SEC, will contain important information about the proposed business combination and the other matters to be voted upon at a
meeting of ESGEN&#146;s stockholders to be held to approve the proposed business combination (and related matters). This news release does not contain all the information that should be considered concerning the proposed business combination and
other matters and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. ESGEN may also file other documents with the&nbsp;SEC&nbsp;regarding the proposed business combination. ESGEN
stockholders and other interested persons are advised to read the preliminary proxy statement/prospectus and the amendments thereto and the definitive proxy statement/prospectus and other documents filed in connection with the proposed business
combination, as these materials will contain important information about ESGEN, Sunergy and the proposed business combination. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>When available, the
definitive proxy statement/prospectus and other relevant materials for the proposed business combination will be mailed to ESGEN stockholders as of a record date to be established for voting on the proposed business combination. Stockholders will
also be able to obtain copies of the preliminary proxy statement/prospectus, the definitive proxy statement/prospectus and other documents filed or that will be filed with the&nbsp;SEC, free of charge, by ESGEN through the website maintained by
the&nbsp;SEC&nbsp;at&nbsp;<U>www.sec.gov</U>, or by directing a request to:&nbsp;ESGEN Acquisition Corporation, 5956 Sherry Lane, Suite 1400, Dallas, TX 75225. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Participants in the Solicitation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>ESGEN and
Sunergy and their respective directors, officers and related persons may be deemed participants in the solicitation of proxies of ESGEN stockholders in connection with the proposed business combination. ESGEN stockholders and other interested
persons may obtain, without charge, more detailed information regarding the directors and officers of ESGEN, and a description of their interests in ESGEN is contained in ESGEN&#146;s final prospectus related to its initial public offering,
dated&nbsp;October 21, 2021, the Annual Report&nbsp;and in ESGEN&#146;s subsequent period reports and other filings with the&nbsp;SEC. Information regarding the persons who may, under&nbsp;SEC&nbsp;rules, be deemed participants in the solicitation
</I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g662816dsp12.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g662816dsp12a.jpg" ALT="LOGO">
</TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
of proxies to ESGEN stockholders in connection with the proposed business combination and other matters to be voted upon at the ESGEN shareholder meeting is set forth in the Registration
Statement. Additional information regarding the interests of participants in the solicitation of proxies in connection with the proposed business combination will be included in the Registration Statement that ESGEN&nbsp;intends to file with
the&nbsp;SEC. You may obtain free copies of these documents as described in the preceding paragraph. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sunergy Contacts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>For Investors: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cody Slach and Tom Colton </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gateway Group </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>sunergy@gatewayir.com </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>For Media: </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zach Kadletz and Anna Rutter </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gateway Group </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>sunergy@gatewayir.com </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ESGEN Acquisition Corp. Contacts </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>For Media&nbsp;&amp;
Investors: </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nader Daylami </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>nader@esgen-spac.com
</U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>esac-20240124.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 72.1.1 -->
<!-- Creation date: 1/25/2024 3:23:13 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:esac="http://www.esgen-spac.com/20240124"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:us-types="http://fasb.org/us-types/2023"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.esgen-spac.com/20240124"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" namespace="http://fasb.org/us-types/2023" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="esac-20240124_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="esac-20240124_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="esac-20240124_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>esac-20240124_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 72.1.1 -->
<!-- Creation date: 1/25/2024 3:23:15 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="esac-20240124.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:type="locator" xlink:label="dei_DocumentInformationTable" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalUnitsMember" xlink:type="locator" xlink:label="us-gaap_CapitalUnitsMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0.01" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CapitalUnitsMember" order="19" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="22" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_WarrantMember" order="23" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="37.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="40.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="41.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="47.001" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="48.001" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>esac-20240124_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 72.1.1 -->
<!-- Creation date: 1/25/2024 3:23:13 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:type="locator" xlink:label="dei_DocumentInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Table]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalUnitsMember" xlink:type="locator" xlink:label="us-gaap_CapitalUnitsMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalUnitsMember" xlink:to="us-gaap_CapitalUnitsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Units, each consisting of one share of Class A ordinary share, $0.0001 par value, and one-half of one warrant redeemable warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CapitalUnitsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Units, each consisting of one share of Class A ordinary share, $0.0001 par value, and one-half of one warrant redeemable warrant [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Class A [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 1</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line 2</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line 2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>esac-20240124_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 72.1.1 -->
<!-- Creation date: 1/25/2024 3:23:13 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="esac-20240124.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:type="locator" xlink:label="dei_DocumentInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0.01" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalUnitsMember" xlink:type="locator" xlink:label="us-gaap_CapitalUnitsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CapitalUnitsMember" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember" xlink:type="locator" xlink:label="us-gaap_CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_WarrantMember" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="26.131" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="26.231" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g662816dsp12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g662816dsp12.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  @ ,0# 2(  A$! Q$!_\0
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MUO\ P4 _;E\,_P#!.O\ 9JU+XH>+M,US5]$TN[MK22VTB.)[IFGD$:D"1T7
M)Y^;I7YS_P#!/O\ Y6I?VH_^Q6F_]#T>O<_^#HWG_@D%XO\ ^PWI'_I6E 'U
MI^P]^VEX-_X* ?LW:'\3O LEW_8NM&2)[6]5$O-/GB<I)!,JLP5P0#PQ!5E8
M'#"N$_X)T_\ !43P3_P4LB\>MX-T3Q1HP^'NJ)I-_P#VS#!']HD?S,-%Y4LF
M5_=G[V#R.*_*_P#X(._%C7_^"6?[9/A3X+^.-0,OPY_:<\*Z/XP\(W[_ "P1
MZE=VB/&@Y(5W;S+1P.6DBMCPI%>T?\&G0Q:?M._]CI;_ ,KJ@#[6_P""G_\
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M7)XBU!9]'\%:%OL_"GA[?^[TNU)'SN!\IN)-JF1AZ*H.U%KYR^&_PXUWXO\
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;LUU,WHM+;[81M-QY2^:1TQNQF@"U1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g662816dsp12a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g662816dsp12a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  ; ' # 2(  A$! Q$!_\0
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L)IUEK#VRF\MK:0Y>)9,;@A/;IR?4TX3LG$G%89SG&<'9W5_-)I_?V]6?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm140280608657504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 24, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 24,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ESGEN ACQUISITION CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1601409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">5956 Sherry Lane<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 1400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">75225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">987-6100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001865506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CapitalUnitsMember', window );">Units, each consisting of one share of Class A ordinary share, $0.0001 par value, and one-half of one warrant redeemable warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ESACU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Class A ordinary shares included as part of the units<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ESAC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ESACW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CapitalUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CapitalUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>d662816d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="esac-20240124.xsd" xlink:type="simple"/>
    <context id="duration_2024-01-24_to_2024-01-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001865506</identifier>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-24</endDate>
        </period>
    </context>
    <context id="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CapitalUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001865506</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CapitalUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-24</endDate>
        </period>
    </context>
    <context id="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001865506</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-24</endDate>
        </period>
    </context>
    <context id="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001865506</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-24</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-01-24_to_2024-01-24"
      id="Hidden_dei_EntityCentralIndexKey_duration_2024-01-24_to_2024-01-24">0001865506</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2024-01-24_to_2024-01-24"
      id="Hidden_dei_AmendmentFlag_duration_2024-01-24_to_2024-01-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2024-01-24_to_2024-01-24" id="Fact_1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-01-24_to_2024-01-24" id="Fact_0">2024-01-24</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-01-24_to_2024-01-24">ESGEN ACQUISITION CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-01-24_to_2024-01-24">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-01-24_to_2024-01-24">001-40927</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-01-24_to_2024-01-24">98-1601409</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-01-24_to_2024-01-24">5956 Sherry Lane</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-01-24_to_2024-01-24">Suite 1400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-01-24_to_2024-01-24">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-01-24_to_2024-01-24">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-01-24_to_2024-01-24">75225</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-01-24_to_2024-01-24" id="Fact_2">214</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-01-24_to_2024-01-24" id="Fact_3">987-6100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-01-24_to_2024-01-24">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-01-24_to_2024-01-24">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-01-24_to_2024-01-24">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-01-24_to_2024-01-24">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CapitalUnitsMember"
      id="Fact_4">Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CapitalUnitsMember">ESACU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CapitalUnitsMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">Class A ordinary shares included as part of the units</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">ESAC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-CommonClassAMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">ESACW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-01-24_to_2024-01-24_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-01-24_to_2024-01-24">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2024-01-24_to_2024-01-24">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0FFJ\LU,>6+DJG@;,I?&R+0XC#F#S:&] ;Y?2&F>3NP+ENK]V. ?4$L#!!0
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( #M'.5@'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ .T<Y6 N=AT?N    *P(  !$
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M;',O+G)E;'-02P$"% ,4    "  [1SE8'#AEZC\!   \ @  #P
M    @ &B$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ .T<Y6"0>FZ*M
M    ^ $  !H              ( !#A,  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ .T<Y6&60>9(9 0  SP,  !,
M ( !\Q,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  /14
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d662816d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d662816d8k.htm">d662816d8k.htm</File>
    <File>esac-20240124.xsd</File>
    <File>esac-20240124_def.xml</File>
    <File>esac-20240124_lab.xml</File>
    <File>esac-20240124_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d662816d8k.htm": {
   "nsprefix": "esac",
   "nsuri": "http://www.esgen-spac.com/20240124",
   "dts": {
    "inline": {
     "local": [
      "d662816d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "esac-20240124.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "esac-20240124_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "esac-20240124_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "esac-20240124_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 32,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 30
   },
   "report": {
    "R1": {
     "role": "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "000001 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-01-24_to_2024-01-24",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d662816d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-01-24_to_2024-01-24",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d662816d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "terseLabel": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalUnitsMember",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units, each consisting of one share of Class A ordinary share, $0.0001 par value, and one-half of one warrant redeemable warrant [Member]",
        "terseLabel": "Units, each consisting of one share of Class A ordinary share, $0.0001 par value, and one-half of one warrant redeemable warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "terseLabel": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "terseLabel": "Class A Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]",
        "terseLabel": "Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.esgen-spac.com//20240124/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-24-014919-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-014919-xbrl.zip
M4$L#!!0    ( #M'.5C4E$P*.RP  /,/ 0 .    9#8V,C@Q-F0X:RYH=&WM
M/6M3V\B6W[=J_T,7,W,7JFQC&TB )&PQA,RP-T.R0'9F]\M46VK;FLB21@_
M]]?O>71++5GR@]CDQ53=&ZQ7=Y\^[U>__,_[B2]N59QX8?!JJ]?I;@D5.*'K
M!:-76UDZ;!]NB?\\^?=_>SE.X4%X.$B.W31NI]-():^VQFD:'>_NWMW==>X'
ML=\)X]$NW-[%V[O];K_?[NZU]WI;^LU[WPL^EMZZVZ-W>D='1[MTUSPZ\V3^
M_7ZWN[>+MP<R4>9QE4BG]+A*1BIH)Y%T.DXXP;GL=WO]_7PFB5<W#_AV;_>/
MW]Y>.V,UD6TO2%(9./DH61HWSNEH%^Z:![TDW._WGL]9@'XB?^&^Z=D>/!O
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M,L>?LP2H%[1R$%@#X+C$/O-5B'QO&L316J9^BMP<N#YG[[E>XO@A2("6P*F
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MMZ"1?$78+ _?VMEW'F??-:,KA0D<B44)+%)"[:0D+Q"(MTG(7B-2%YIFAJ9
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M>__-GC<RV^F/#\/4+M G;-#8T']\;.A;V%#MT=/4R/R!"%'?4OUIZ[=.L-W
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M<Q(  $]F   1    9#8V,C@Q-F1E>#$P,2YH=&WM76ES&DG2_DX$_Z%"$]Y
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M(=95KTJLBX4DL[Y6*3.=9Y=6<PG,Q> 7 "R0B!+CDS^B &T=&0R(BF#IRC#
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M'LU_>CV.'P&[2@I2/?#AUSS;#C_&^IHJI"TS_P@:3/!?1T>&$_ACL*V'1MH
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MQM$"")S#H2M1)Z\4QY>=CL?U+0O]#60*D*?Q60Z/EA=H'FP\;IN1'S=K(_D
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MN&H)Z-689VOTA 2\EP5:XVWP2C=D1ECS/M<.^A[8]:C+/G:#2EUFY*U8C_:
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MRBE=,7.>^( !8>>2<S$\N@R]CNTQ*"6H"'-WGQJ(>Z >ZUCP4EC>R1_;X'_
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M8>" X7^T&=O*R3QH-M_Z%&,S4Y\5,6$1:*QC(T51!E@R(;<WO*BH%GB]*':
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M2&8EJ(X,&T4(T^TNO1!-?:O"?!(5!JR(([=?-]]1[MJ)_I)HX6QOD;71$+F
M.FX0AW,-4#AG=9)3,84#0$?_<W7THZ6N>0^D.VL2J/@@N8@6,='2.+B 1<*N
M@'4^P4%V]K9;[7-I&%Q>P&W0=X(B^4(1AJ<M(09*DCYJV1&F+&L*$]![BRU,
MB 9]4B&ZC))II/#E)!I1&K54V @KM!U$VFUFNB'$:(#%3^C8*+.$N3^7"38U
MQS'F=V:+@%L!S!UWLR+(507!_AIW@Y$0P,^,QZPM #DGH *\RR]-Q2VZOZ]
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MLT<8QJQ'"H:PHOC0G)I3*8*ED^@4#9O:G@8;D2$ (VN=":>JQ6.]*!9<!S1
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M8=_3H1?0OD7[,I(23R9_%.U9Y/GJ/-_10>R)!MQR\""E"X,7#N6HTRXM0!V
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M,BI]WNQ:@YS)D=."O1:(B7TB@.*.W[2$?8X7I@%N//)&N/4 T&CDQ!-4E&E
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M*KGS]2*S P6A//2]$6*IR\F>V?%1>*#3[A]I,0@2F2B6]K59%"L5\BLG)C$
MYX$]&'EJ"];BT->6(543EH,N>_I1V8V,I$D4^G@LL0?$Z\#QA$%*0(@E,&-"
MAIES8^("#!;$J/!&RBV];?,(_,"AVKS;+XQRO^873@>*UG1)9T:6:8.<0\T\
M>23 O-+D@(,BCJ$GAC *U@$;\YMJJ40DUBX'SC>2XO1F\\G&&':?8PQ+0!,&
M!R4D''E,N<C&$(<V$2,=%5L#Y"+67<71E6\G3J?3G)/"9N8F#)\+/W>4KV^,
M-B51X!D34'7.14Y79 HD'HEI%YIG :N=>G%,<QHZ92U>Z>"8N@<\*QQI1K6
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MT9_?MLP5T$& F]1K6>L_AYB!:BN4I6!3+XO1*,(.&@O[LU(#PS  S92+.AS
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MPZ1HI99&9\R=AY;=SEM2K)B"0!Q[OA%1$#XDQP)>N"+_#A<>&=8\& O6!13
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M^*.PE[MZ>^(6@F&&N-D<(VE8#E5!I#3W0%Z)5>FZYH<'<%4R=:L%@/+^N@=
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MKE:]O,CF]EI(FENN$E6+UW[^!E!+ P04    "  [1SE8]+WWE^0%  !O.
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M-F1E>#(Q+FAT;5!+ 0(4 Q0    ( #M'.5AZ7MS\)!L   !G   1
M      "  ?S3  !D-C8R.#$V9&5X.3DQ+FAT;5!+ 0(4 Q0    ( #M'.5BM
MJ3_-*0,  #(,   1              "  4_O  !E<V%C+3(P,C0P,3(T+GAS
M9%!+ 0(4 Q0    ( #M'.5CTO?>7Y 4  &\X   5              "  :?R
M  !E<V%C+3(P,C0P,3(T7V1E9BYX;6Q02P$"% ,4    "  [1SE8^\+J'&L(
M  #17P  %0              @ &^^   97-A8RTR,#(T,#$R-%]L86(N>&UL
M4$L! A0#%     @ .T<Y6! C5R*)!0  \SL  !4              ( !7 $!
L &5S86,M,C R-# Q,C1?<')E+GAM;%!+!08     "0 ) #\"   8!P$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
